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ABSTRACT 
 Precise regulation of gene expression is essential for maintaining cell homeostasis 
and survival. Rapid responses to intracellular or extracellular stimuli involve highly 
regulated genome-wide changes in the transcriptional landscape. However, works on 
transcriptional regulation thus far has been primarily focused on genes and gene promoters. 
Consequently, ubiquitous transcription outside of genes has been greatly neglected. 
Therefore, in order to understand genome-wide transcriptional changes with stimuli, we 
looked at transcription factor distribution, RNA Polymerase II (Pol II) dynamics, histone 
changes, chromatin accessibility at both promoters and promoter-distal regions along with 
changes in gene transcription. With this approach, we were able to create a more 
comprehensive picture of how cells respond when exposed to stimuli. 
 Previous studies in mouse and human cells have shown with heat stress at elevated 
temperature, there is massive genome-wide binding of transcription factor HSF1 (Heat-
Shock Factor 1) (Mahat et al., 2016; Vihervaara et al., 2017). Genome-wide analyses 
revealed there are approximately 280,000 HSF1 binding elements in the human genome. 
However, with heat-shock, HSF1 binds to less than 4% of these sites indicating HSF1 
binding might be context-dependent. To address whether HSF1 binding depends upon 
stimulus and/or cell-type, we exposed two different cell types, MCF7 breast cancer and 
K562 chronic myelogenous leukemia cells to a heat-dependent (heat stress at 43°C) and a 
heat-independent stress (Arsenic) and compared genome-wide changes in HSF1 
distribution, histone marks, RNA Pol II and nascent transcription. We found HSF1 binds 
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across the entire human genome during HSR and is a highly sensitive indicator of global 
heat-shock response (HSR) among the marks we tested. This genome-wide HSF1 binding 
is independent of stress type but is dependent on cell type. This cell type specific difference 
in HSF1 binding is more prominent at distal intergenic regions rather than at promoters. 
The mechanism of this difference in HSF1 binding in different cell types might not be 
dependent on chromatin accessibility as detected by ATAC-sequencing but might be 
potentially pre-determined at ground state of cells maintaining cells in a poised state for 
rapid orchestration of HSR.   
 We next studied the dynamics of RNA Polymerase (Pol II) regulation and gene 
expression under different stresses and different human cell types. HSR has been associated 
with massive repression of gene expression due to elevated temperature (Mahat et al., 
2016; Vihervaara et al., 2017). We found this repression is cell type dependent and takes 
place by distinct cell-specific mechanisms. Regulation of gene expression at the level of 
Pol II can occur at two steps: (i) during recruitment of Pol II at promoter and (ii) during 
release of Pol II from promoter-paused site to gene body.  We found this mechanism of 
recruitment versus release at promoter differs between cell types and can, in turn, explain 
the cell-type specific extent of repression.  
 These studies indicated that distal intergenic regions or potential enhancer regions 
might be important regulatory elements showing significant transcriptional changes with 
stress. Therefore, we next utilized another biological model of IL-1β -induced 
inflammation in lung adenocarcinoma cells (A549) to investigate the role of enhancers in 
gene regulation. We found that rapid genome-wide transcriptional changes take place in 
A549 cells induced with IL-1β. Transcription at genes and their nearest predicted 
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enhancers display similar patterns of expression changes with inflammation. We further 
found that RNA production at genes and enhancers are not separated by time but are co-
transcriptional events.  
 In conclusion, this dissertation demonstrates that cells undergo rapid and robust 
genome-wide transcriptional changes with inflammatory or environmental stresses 
affecting gene-promoters, gene-bodies as well as extragenic regulatory elements such as 
enhancers. The mechanisms of these transcriptional changes to stress responses in different 
cell types under different conditions might be determined during cell lineage specification 
and is probably dependent on the availability of cell-specific transcriptional regulators 





1.1  Motivation 
 Our bodies are exposed to various kinds of intracellular and extracellular or 
environmental stresses throughout our lifetime. As a response to these stresses, cells have 
evolved mechanisms to induce rapid changes in their molecular machinery to maintain 
homeostasis and fight these stresses. These stress-responses are extremely precise and 
well-regulated and, take place within seconds of exposure to the stress-inducing stimuli. 
Cells activate stress-specific pathways leading to synthesis of stress-response proteins that 
buffers the effect of stress and protect the cells from dying. Stress response mechanisms 
are present in almost all eukaryotic organisms studied, from yeast to mammals and play 
critical roles during development and cell-fate determination as well as in diseased states 
such as cancer. My dissertation focuses on investigating the mechanisms of rapid changes 
that cells undergo in their transcriptional landscape in response to the environmental and 
inflammatory stresses.   In this chapter, I will start by discussing the fundamental concepts 
and later introduce the specific questions that I have addressed in my thesis. 
1.2  Transcription 
 Transcription is the process wherein an RNA molecule is synthesized from the 
DNA template. Transcription is a highly regulated process involving enzymes and 
molecular machinery that is highly conserved from bacteria and archaea to eukaryotes1.
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The transcription cycle in all organisms involves three major steps, initiation, elongation 
and termination, after which the transcription machinery releases the DNA strand and 
might be recycled for the next round of transcription. Each of these steps are precisely 
regulated by multiple factors including nucleosome positioning and chromatin 
accessibility, gene regulatory elements such as promoters and enhancers, binding of 
transcription factors (TFs), and assemblage of the essential proteins to form the 
transcriptional machinery (Fig 1.1). 
 
Figure 1. 1.  Schematic representation of the process of transcription by  
RNA Polymerase II. 
 
 I would briefly elucidate each step of the transcription process and the regulatory 
check points in them, the key factors involved in transcription and the role of the chief 
gene-regulatory elements such as promoters and enhancers in transcription. 
1.3  Regulatory Steps During Transcription 
1.3.1  Transcription initiation 
 Initiation of transcription occurs from a defined region at the 5’ end of the target 
gene also known as ‘transcription start site’ (TSS) that is present within the core promoter 
(explained later) where the transcriptional machinery binds and forms the transcription pre-
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initiation complex (PIC). This PIC comprises RNA Polymerase II (Pol II) and general 
transcription factors (GTFs) such as TATA-binding protein (TBP), TFIIA, TFIIB, TFIID, 
TFIIE, TFIIF, and TFIIH2.  The transcriptional machinery assembles on the promoter 
region, loosen and unwind DNA, place the template DNA strand in the active site of Pol II 
and the machinery start moving along the DNA producing an RNA transcript (Fig 1.2).  
 
Figure 1. 2.  Figure showing RNA Polymerase II in the act of transcription. Figure 
taken from Molecular Biology of the Cell. 4th edition., Alberts B, 
Johnson A, Lewis J, et al., New York: Garland Science; 2002 
 
 Recent studies show that transcription initiation is not a continuous process but 
takes place as discrete events called ‘bursts’. ‘Transcriptional bursting’3,4,5,6 is a process in 
which  genes either exist in an “ON” (burst initiation) state or an “OFF” (burst termination) 
state and RNAs are produced in discrete episodic bursts marked by long periods of 
inactivity5. Bursting can occur by various mechanisms. Single-molecule studies in E. coli 
suggest DNA topology is an important contributor for bursting phenomenon. According to 
Chong et al, 2014 bursting happens because of the positive and negative supercoils present 
within the DNA introducing torque during transcriptional elongation7. Asynchronous 
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generation of these coils and limitation of enzyme gyrase that relieves positive supercoiling 
by inserting DNA double-stranded breaks cause the transcriptional machinery to halt. 
Increase in gyrase concentration releases positive super-coiling resulting in transcriptional 
bursting. In eukaryotes, bursting is gene-specific and more complicated than prokayotes8. 
Mutations in TATA-box9, in promoter regions10, and in factors of pre-initiation complex 
can change the frequency and size of bursting8. A single event of bursting can produce 
from 2 RNA molecules to hundreds of RNA molecules8. Presence of transcription factors 
can increase bursting frequency by increasing recruitment of Pol II at TSS11. Transcription 
factors might also increase bursting frequency by facilitating enhancer-promoter 
interaction. This might explain how transcription factor binding leads to increased gene 
expression.  However, the rate, frequency and size of bursting depends on multiple other 
factors such as cell size, chromatin complexity, promoter strength etc. and thus needs 
further investigation.  
After initiation, transcription machinery encounters a second checkpoint known as 
Pol II pausing. 
1.3.2  RNA Polymerase II (Pol II) Pausing 
 Pol II pausing is a key rate-limiting step in the process of transcription and a major 
checkpoint before elongation. 
 Evidence of Pol II pausing was first reported in early 1980’s in human HeLa cells 
treated with 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazde (DRB)12 and, in beta-
globin gene of hen erythrocytes13 where they observed premature termination of 
transcription and shorter RNA transcript12,13 than normal-length mRNA. In 1986, David 
Gilmour and John Lis reported high concentrations of Pol II near the 5’ end of heat-shock 
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gene hsp70. They saw Pol II accumulation mainly between -12 and +65 nucleotides relative 
to the TSS in inactive Schneider line 2 cells of Drosophila melanogaster14. However, with 
heat-shock induction, they noticed high levels of Pol II all across the gene14 indicating that 
this Pol II stalling is temporary and is released when the gene becomes active. In 1990, 
Lis’s laboratory showed that Pol II pausing is a widespread event occurring at other heat-
shock responsive genes as well as other constitutively expressed genes15.  In initial 
genome-wide studies, approximately 30% of genes were reported to display Pol II pausing 
and this fraction has been confirmed by performing nascent RNA analysis such as GRO-
seq in various cells such as human lung fibroblasts 16,17, mouse embryonic stem (ES) cells 
16,18 and Drosophila S2 cells 16,19. However, depending on which method is used and in 
which system, Pol II has been found to be stalled on 30% -70% of actively transcribed 
genes at ground state20,21,22. Recently, it has been shown in rat neurons that Pol II pausing 
is almost always associated with all transcriptional events taking place at or outside of gene 
promoters23. 
 Paused Pol II has been shown to be relatively stable  compared to other steps of 
transcription, with a half-life of approximately 6 min in Drosophila or mammalian cells24. 
This stability allows for signal co-ordination from other transcription regulatory 
components. Based on the signals received, Pol II either continues to make a new transcript 
or aborts transcription. However, the mechanisms of how Pol II pausing is regulated – 
factors involved in pausing and pause-release, and consequences of Pol II pausing are still 
open questions in the field. Current understanding in the field is that Pol II pausing is 
mediated by Negative Elongation Factor (NELF)25 and DRB-sensitivity inducing factor 
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(DSIF) acting together while pause release is mediated by positive transcription elongation 
factor b (p-TEFb)26, a component of super-elongation complex (SEC)27.  
NELF complex is a highly conserved transcriptional complex and are found to be 
present in most higher eukaryotes studied except Caenorhabditis elegans, Saccharomyces 
cerevisiae, and Arabidopsis thaliana28,25. NELF contains 4 sub-units – NELF-A, NELF-B, 
NELF-C/D, and NELF-E. The current model of Pol II pausing proposes that NELF along 
with other factors such as DSIF binds to Pol II and ‘stalls’ the elongating Pol II. P-TEFb, 
which comprises of Cdk9 kinase and one of the several cyclins (Cyclin T1, Cyclin T2a, 
Cyclin 2b, Cyclin K)26 in mammals, phosphorylates NELF and Pol II CTD at Ser 2 causing 
it to be released from stalled Pol II which then resumes transcription25,26. However, there 
have been other factors that are recently being identified such as PAF129, additional 
members of Super elongation complex (SEC)27 which are shown to either stabilize pausing 
or aid in pause release. The interplay of multiple regulatory factors makes Pol II pausing a 
highly complicated event more than just an ON/OFF switch needing to be carefully 
dissected and studied. 
1.3.3  Transcription Elongation 
 Ironically, rather than being a repressive event, Pol II pausing is required for 
efficient transcriptional elongation in-vivo30. In Drosophila, partial knock-down of NELF 
with siRNA leads to decreased Pol II occupancy at promoters of active genes, and multiple 
promoters eventually get occupied by histones leading to their permanent repression31. 
Transcriptional elongation is the major step where a full-length RNA transcript is produced 
by Pol II and is also a highly regulated step of transcription. Single-molecule studies show 
that this rate of production of RNA varies between genes and can be almost threefold 
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different affecting mRNA accumulation. This variation in transcription rate can serve as a 
key regulatory step during various developmental processes20. In addition to differences 
among individual genes, the speed of Pol II elongation is not constant across the entire 
gene; near promoters Pol II transcribes at a rate of 0.5kb/minute whereas after 
approximately 15kb, the rate of elongation becomes 2-5kb/minute20,32,33. Pol II elongation 
is further regulated by co-transcriptional events including splicing of introns, mRNA 
cleavage and polyadenylation sites20. The time frame of Pol II elongation is consistent with 
the time taken for co-transcriptional splicing which is estimated to be around 20-30 
seconds20,21,34. Pol II elongation is also additionally controlled by helicases such as 
RECQL5 which is known to directly interact with Pol II and stall its progression35 whereas 
TFIIS and elongin help in Pol II progression36. 
1.3.4  Transcription Termination 
 Termination occurs when the nascent RNA transcript and RNA Pol II is released 
from DNA and is essential for proper formation of mature RNA products. Failure to 
terminate transcription can lead to serious consequences. For genes arranged in clusters or 
in divergent orientation, Pol II if not stopped, can slide from the downstream region of a 
target gene to the promoter region of the next gene interfering with its activity – a process 
called ‘transcriptional interference’37,38 ; the transcriptional machinery can also collide with 
DNA replication fork and lead to genomic instability39. For genes arranged in convergent 
orientation, failure to terminate may result in production of overlapping transcripts that can 
act as siRNA bringing down gene expression40,41,42. 
 Transcription termination is an extremely complicated and well-regulated process. 
There are a few models on transcription termination. The ‘torpedo’ model of termination 
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states that Pol II continues to synthesize nascent RNA transcript even after cleavage at 
poly-adenylation site (PAS) at the 3’-end39. Nuclear XRN2, a 5’ to 3’ exonuclease, comes 
as a “torpedo” and degrades the upstream transcript in kinetic competition with the 
elongating Pol II finally catching up with the “battleship” which here is Pol II and 
dissociating it from DNA39. The ‘allosteric’ model of termination proposes elongating Pol 
II can sense when it is near an active PAS leading to conformational changes in the active 
site of the polymerase causing dissociation of the molecule from DNA39. At certain DNA 
sequences Pol II can, instead of moving forward, move backward. This event is called 
backtracking and has recently been found to be a widespread occurrence43. Backtracking 
can lead to disassembly of Pol II from DNA by inducing conformation changes of Pol II 
ultimately resulting in transcription termination44. 
1.4  Key Players of Transcription 
1.4.1  RNA Polymerase II (Pol II) 
 Although the basic mechanisms of transcription remain the same, regulation of 
eukaryotic transcription is much more complex than in prokaryotes1. While bacteria and 
archaea have only one polymerase, eukaryotes have three polymerases (RNA Pol I, RNA 
Pol II, and RNA Pol III) to synthesize specific classes of RNA. However, most of the 
subunits of different polymerases are homologous to each other, implying that they have 
the same basic structure and function. 
 Pol II is the primary enzyme that is responsible for eukaryotic mRNA transcription. 
Transcription by RNA polymerase II is more complicated than transcription by any other 
polymerases involving nearly 60 polypeptides whereas the other polymerases requires only 
a few of these subunits. Different stages of transcription is precisely controlled by different 
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states of Pol II phosphorylation and dephosphorylation at the C-terminal domain (CTD) of 
its largest subunit RPB1 (Fig 1.3). The CTD of mammalian Pol II is composed of 52 repeats 
of the consensus sequence Y1 S2 P3 T4 S5 P6 S7 and each hydroxyl-containing residue is 
phosphorylated or dephosphorylated at specific steps of transcription45. During the 
formation of transcription pre-initiation complex (PIC), Pol II is completely 
dephosphorylated46,47. However, during initiation and productive elongation, Pol II 
exhibits different phosphorylation states. The states of Pol II phosphorylation and the 
mediating enzymes are listed in the table below (Table 1.1). 
 
Figure 1. 3.  ChIP-enrichment data of CTD phosphorylation residues in different 
stages of transcription in S. cerevisiae. The y-axis indicates 
approximate ChIP-enrichments found in genomic tiling arrays and the 
x-axis indicates approximate stage of transcription. Figure reused from 
Mayfield et al., 2016 Biochim Biophys Acta. 2016 Apr: 1864(4): 382–



















1.4.2  Transcription Factors 
 Transcription factors (TFs) are an essential component of gene regulation. There 
are almost 1500 to 2000 TFs that are encoded by human genome48,49. TFs can be broadly 
divided into two groups: the first group control transcription during (i) initiation and the 
second group that control during (ii) elongation50. However, some TFs can control 
transcription during both initiation and elongation. TFs bind to their cognate DNA-binding 
motifs, attract co-factors that otherwise cannot bind to DNA, and mediate activation or 
repression of transcription50. TFs can bind to gene-regulatory elements such as promoters 
and enhancers as well as other regulatory-regions of DNA such as silencers and insulators 
and control gene expression51. Generally, eukaryotic TF recognize small 6-12bp long 
degenerate DNA sequences51 suggesting that there are other modules of regulation, more 
than just sequence-specificity that govern TF binding to a site. It has been shown that the 
time of TF occupancy at a particular locus and the region that it binds to can play significant 
role in controlling gene expression51. For example, in Drosophila melanogaster mesoderm-
specific TFs are present all along during development. But they have been shown to bind 
Table 1.1 Table illustrating the different states of Pol II during transcription and 
the mediating enzymes 
 








Initiation Serine 5 (Ser 5), Serine 7 (Ser 7) Cyclin-dependent 
kinase 7 (Cdk 7), 
a subunit of 
TFIIH 
Pausing Serine 5 Cdk 7 
Productive 
elongation 
Serine 2 (Ser 2) Cdk 9 subunit of 
P-TEFb 
Termination Serine 2 Cdk 9 
Backtracking Serine 2 Cdk 9 
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only particular sets of enhancers at specific developmental stages, implying the temporal 
specificity with which TFs bind genomic regions52.  
 Multiple TFs can bind to regulatory regions using different mechanisms that can 
result in very different outputs.  
(i) Co-operative binding of TF: When TFs bind to adjacent sites on DNA, often 
facilitated by protein-protein interaction between them. This can produce a 
binary on-off switch-like effect and this pattern of TF binding is prevalent 
during determination of cell lineage. For example, during early Drosophila 
development, Bicoid TF expression is sharply controlled and binds only above 
a certain threshold leading to precise expression of only Bicoid target genes51,53. 
(ii) Assisted loading or collaborative competition model of TF binding: 
Competition between TFs for the same site might result in net increase of TF 
binding by inhibiting nucleosome repositioning54. 
(iii) Changes in chromatin conformation: TFs can lead to local DNA bending 
bringing about conformational changes of chromatin causing distant regulatory 
elements like enhancers and promoters to come closer to each other 51,55,56. 
(iv) Pioneer factor TFs: These TFs are a special class of recently identified TFs that 
has been shown to possess some unique properties. They can interact with their 
binding motifs present on nucleosome-occupied chromatin and can induce 
changes in chromatin accessibility. They melt chromatin regions and can 
increase local chromatin openness helping other reprogramming factors to bind 
to the open region. They act as major deterministic factors in cell-fate 
decisions48,57,58. For example: GATA3 acts as a pioneer factor in the cellular 
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process of mesenchymal-to-epithelial transition in breast cancer cells. GATA3 
evicts histones from nucleosome-occupied chromatin in some regions and binds 
previously-inaccessible DNA and regulates transcription48. 
 TF binding to chromatin is also regulated by motif sequence and motif location51. 
Both presence of TF binding motif and, distance, position and orientation of the motifs can 
determine consequence of TF binding. For example, IFN-b enhancer is 55 bp long and 
serves as the binding site for NFkB, IRF1, ATF2/c-Jun, CBP/p300 and architectural protein 
HMG I (Y)59,60. Binding of these factors on IFN-b enhancer forms a functional 
enhanceosome which regulate IFN-b gene transcription. However, changes in motif 
sequence of any of these TFs can drastically affect the binding capacity of all the TFs that 
have binding sites on IFN-b enhancer 51,56,61. 
1.4.3  Nucleosomes in Transcription 
 The 2-meter long human DNA is fragmented into small pieces and is tightly 
packaged with nucleosomal proteins to form structured units called chromatin. This 
chromatin is then further condensed into stable organizational units called chromosomes. 
Humans have 46 chromosomes and they are all housed into an approximately 6 µm sized 
compartment in the cell called nuclei. Nucleosomes form the building blocks of chromatin 
and comprise four core histone proteins H2A, H2B, H3 and H4 and, histone H1 linker 
protein. Eight of these core histone proteins form an octamer around which 147 base pairs 
of DNA is wrapped62. Histone proteins have unstructured N-terminal tails that are heavily 
post-translationally modified. Some of the identified post-translation modifications (PTM) 
include acetylation, methylation, phosphorylation, ubiquitylation, sumoylation, ADP 
ribosylation, deimination, biotinylation, butyrylation, krotonylation, N-formylation, and 
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proline isomerization62. These PTMs give unique functional identity to the histones and 
combinatorial activity of these modified histones establishes the ‘histone code’63. Based on 
these epigenetic ‘codes’, a gene can exist in different states such as active, inactive or 
poised. Histone H1 or linker histone binds DNA at its entry or exit point from nucleosomes 
and has also been found to harbor PTMs. These PTMs at histones serve as a major 
deterministic factor of chromatin states - whether regions of chromatin will be open and in 
a euchromatin region versus closed and part of a heterochromatin region. The process of 
dosage compensation and X-chromosome inactivation in mammals especially highlight the 
role of histones in switching off active chromatin regions into heterochromatin regions. X-
chromosome inactivation is marked by the association of Xi-non coding RNA (Xist) as 
well as numerous repressive histone marks such as histone deacetylation, histone H3 lysine 
4 (H3K4) demethylation, histone H3 lysine 9 dimethylation (H3K9me2), histone 3 lysine 
27 trimethylation (H3K27me3), histone H4 lysine 20 monomethylation (H4K20me1), 
methylation of CpG islands at promoters, and enrichment of the histone variant macroH2A.  
 Histone modifications are highly dynamic and are continuously being monitored 
by a pool of ‘writer’ and ‘eraser’ proteins that either add or remove chemical modifications 
to histone tails and ensure proper histone functionality. During development, histone 
modifications at promoters and enhancers provide important directions in determination of 
cell differentiation. Aberrant histone methylation has been found to occur in various aging-
related diseases including cancer. The ability of histones to respond to extracellular or 
intracellular signals give chromatin the flexibility to adapt and control gene expression, 
making histones a very interesting subject to study transcriptional dynamics64,65,66.  
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1.5  Gene Regulatory Regions 
1.5.1  Promoters 
 Promoters are the primary regulatory sites for transcription control and have been 
a widely studied topic. Promoter is located at the 5’ end of the gene and can vary in length 
from 100bp to approximately 1000bp. The core promoter is a short approximately 100bp 
sequence and TSS is located near the center of this core promoter67. The core promoter 
contains ‘core promoter elements’ (CPEs)68 and there are ~ 15 different promoter motifs 
that have been identified based on these CPEs: TATA-box, Inr, DPE, MTE, Ohler 1, Ohler 
6, Ohler 7, DRE, TCT, BREu, BREd, DCE (I, II, III), XCPE1, XCPE2, Pause Button. 
Promoters differ in their motifs, transcription factors that bind to them and the strength or 
rate with which they can initiate transcription67,69,70,71.  
 Among the different classes of promoters identified, TATA- containing promoters 
and TATA-less promoters are two major classes of promoters that have been extensively 
studied. TATA-binding proteins (TBPs) recognize the TATAA element, located 30bp 
upstream of the TSS on the core promoter, and bind to DNA along with other TBP-
associated factors (TAFs)71. Transcriptional activators promote TBP binding to promoters 
that in turn leads to the assembly of pre-initiation complex (PIC) at promoters facilitating 
transcription. However, TATA box is present only in a minority (for example ~5% in fly) 
of core promoters but is very conserved from yeast to humans. The Initiator motif or Inr is 
more common than TATA-box but the sequence is not conserved across species. In TATA-
less promoters, the downstream promoter element (DPE) is also present along with Inr and 
the precise position of these two elements is essential for TFIID binding to promoters and 
initiation of transcription69. 
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 Based on these core element motifs, pattern of transcription initiation, chromatin 
conformation and gene activity, promoters are divided into three categories67 (Fig 1.4): 
1. Promoters with sharp or focused initiation patterns, loosely organized nucleosomes 
mainly H3K4me3 – these promoters generally contain TATA-box and Inr motifs 
and are found at genes that are active in terminally differentiated cells. 
2. Promoters with dispersed initiation patterns and precisely positioned nucleosomes 
(H3K4me3) with a defined nucleosome-depleted region - these promoters are 
generally present near or overlap a CpG island and are found at housekeeping genes. 
3. Promoters with precisely positioned nucleosomes and bivalent histone marks such 
as H3K4me3 (active) and H3K27me3 (repressive) – these promoters typically show 
the characteristic of housekeeping promoters but are active in embryonic stem cells 






Figure 1. 4.  Classification of major eukaryotic core promoters based on mode of 
transcription initiation and presence of histone marks. Figure reused 
from Haberle and Stark, 2019, Nat Rev Mol Cell Biol. 2018 Oct; 
19(10): 621–637 with permission 
1.5.2  Enhancers 
 A cell is largely defined by the genes it transcribes50. These sets of genes distinguish 
one cell type from another. Studies show that along with promoters, enhancers also play 
important role in gene regulation. The classical definition of enhancers states that they are 
cis-regulatory DNA sequences that can be located either upstream, downstream or in the 
middle of a gene and irrespective of their distance and orientation, can regulate gene 
transcription72. However, with advancement in technology to identify enhancers, now it is 
being discovered how important enhancer location and orientation is in regulating gene 
expression. It has been estimated that there are ~1 million potential enhancers in the human 
genome making it almost 3% of the entire DNA sequence (assuming each enhancer length 
=100bp)73. This huge population of potential enhancers points to the fact that they have 
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been selected favorably though evolution and in turn raises the question of their functional 
relevance in regulating gene expression. 
 Enhancer was first discovered ~30 years ago in SV40 viruses as a 72bp sequence 
in late gene region of the virus74. The enhancer from SV40 was isolated and cloned near 
beta-globin gene in HeLa cells where it amplified expression of the gene 200-fold74. 
However, due to lack of proper sequencing tools genome-wide study of enhancers were 
impossible to carry out and enhancers remain poorly studied. With the recent emergence 
of global sequencing techniques such as ChIP-seq, PRO-seq, NET-seq and chromatin 
conformation studies such as Hi-C, the field of enhancer biology experienced a rapid 
growth and the profound influence of enhancers on gene regulation have been realized.  
 Recent studies show, unlike what was previously thought, enhancer ‘grammar’ 
(that is, the order, orientation, and spacing of binding sites of regulatory factors on 
enhancers) is critical to precise regulation of gene expression75. Farley et al., 2016 have 
shown that weak enhancers arranged optimally, and strong enhancers with strong-affinity 
binding sites for TFs arranged sub optimally can cause robust gene expression76. This 
precise mechanism of enhancer control through near placement of low TF binding affinity 
sites versus distal placement of high affinity TF binding sites is essential in regulating gene 
expression during development76,77. 
 How enhancers regulate gene expression has always been an interesting question. 
There are several theories suggesting that enhancers act as the platform to bind 
transcription factors (TFs) that then recruit components of Mediator complex which 
together bring in RNA Pol II and mediate long-range interaction with target gene 
promoters78. This long-range enhancer-promoter interaction has been proposed to work in 
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two ways (a) either by looping79 (b) or by tracking Pol II down the DNA and finally 
establishing a connection with promoters78.  
 Recently it has been shown that enhancers can also be transcribed producing 
enhancer RNAs (eRNAs) the function of which is controversial79,80,81,82,83,84. Based on 
transcriptional activity and histone marks, an enhancer can be classified into three classes 
– inactive, poised and active72. 
(i) An inactive enhancer is generally characterized by presence of repressive 
histone marks such as H3K27me3 and Polycomb complex as well as lack of 
any detectable transcription. 
(ii) A poised or primed enhancer is generally marked by bivalent histone marks 
such as H3K4me1 and H3K27me3. When hit with a stimulus, a poised enhancer 
switches to an active state and as a result enhancer RNAs are produced. 
Developmental enhancers and enhancers in stem cells are generally at a poised 
state. 
(iii) An active enhancer is marked by eRNA transcription and presence of active 
histone marks such as H3K4me1 and H3K27ac, and binding of histone 
acetyltransferase such as CBP/p300. 
 These different states of enhancers make them flexible to respond to developmental 
as well as environmental stimuli making them important decision points of cell fate 
determination. Mutations in enhancer sequences have been found to occur in various 
developmental disorders and in diseases including cancer85,86. Looking at mutations in 
enhancer regions is a novel way of identifying underlying causes for diseases and this goes 
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against the traditional method of looking for mutations at only protein-coding genes in 
diseases. 
 Enhancers can be further categorized into shadow enhancers3 and super 
enhancers87. Super-enhancers are large regulatory regions of DNA ranging from 10-20 kb 
in their length which is almost an order of magnitude higher than normal enhancers and act 
as a site to bind multiple TFs88. Super enhancers are also found to be associated with 
increased ES cell specific TF, and hence play a role in maintaining ESC state89. In cancers, 
super enhancers tend to be active near oncogenes such as MYC and FOS90. 
 Shadow enhancers are similar to normal enhancers in structure and functions; they 
are named so as they reside further from the target gene compared to the primary enhancer 
or they are in the ‘shadow’ of the neighboring target gene. Recent studies show that these 
shadow enhancers are responsible for patterning and fine tuning of gene expression and 
play important role in evolution91,92. 
1.5.2.1  Enhancer RNAs. 
 
 Active enhancers marked by H3K4me1, H3K27ac, histone variant H2A.z, 
acetyltransferase p300, Mediator complex and shows open chromatin and DNase I 
hypersensitivity are capable of bringing in Pol II transcription machinery and initiating 
transcription93. eRNAs are generally short 1-2kb transcripts produced by bi-directional 
transcription from enhancer TSS82. The functions of these eRNAs are controversial. 
Studies have shown that eRNAs function in a variety of processes including regulation of 
transcription initiation from target gene promoters and acceleration of transcription by 
releasing NELFe from paused Pol II complex and promoting elongation. Another school 
of thought suggests eRNAs are simply transcriptional by-products. However, it is now 
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getting clear that eRNAs are involved in a diverse array of functions and some eRNAs 
clearly exert pronounced effect on mRNA transcription94. Contradicting previous notions 
that enhancers only accelerate gene expression, it has been shown that intragenic enhancers 
in mouse ESCs transcribe eRNAs that impede Pol II movement restricting transcription 
and inducing premature termination95. However, these intragenic enhancers can serve as 
extragenic enhancers for other genes accelerating their expression. This regulatory process 
between intra- and extra-genic enhancers serves as a powerful mechanism to control gene 
expression, especially during determination of cell lineage.  
 These observations clearly demand further studies of enhancers and eRNA in every 
cell type and determine the function of these small non-coding RNAs. 
1.6  Research Objective 
 Through decades of research in the field, we have accumulated substantial insights 
into regulatory mechanisms of transcription and how these mechanisms change during 
rapid response to stimuli. However, every observation has led to the formation of a new 
question.  
• How do cells maintain transcription when exposed to various intra and extracellular 
stimuli? 
• Which genomic regions are more sensitive and show significant changes in 
response to these stimuli? 
•  How are histones affected during these rapid responses to stimuli? 
• How does the dynamics of TF activity change during rapid response? 
• Do all cells utilize the same mechanisms during rapid response? 
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• How rapidly does our chromatin conformation change when cells undergo rapid 
response? 
 In my dissertation thesis, I would be addressing some of these unanswered 
questions. In my second chapter, I would write about the methods I have used to address 
these questions. In my third chapter, I would characterize similarities and differences 
between heat-dependent and heat-independent stress responses in two different human cell 
types with a focus on the classical transcription factor HSF1, changes in chromatin 
conformation, and dynamics of promoter and enhancer-associated histone marks. In my 
fourth chapter, I would focus on the molecular mechanisms of Pol II transcription in the 
two cell lines exposed to the same stimulus. In my fifth chapter, I would use IL-1b as an 
inflammatory stimulus to elicit rapid transcriptional response in human cells and measure 
changes in genome-wide transcriptional landscape in a time-dependent manner to identify 




2.1  Cell Culture 
 MCF7 human breast adenocarcinoma were obtained from American Type Culture 
Collection (ATCC). Cells were cultured in DMEM/F12 (Life Technologies) media 
supplemented with 10% fetal bovine serum (FBS) (Gibco) at 37°C incubator with 5% CO2.  
 Cells were treated with either heat-shock or Arsenic (Sigma). Heat-shock treatment 
was performed by rapidly placing a cell culture dish at 43°C water bath for 1 minute 
followed by incubation in a dry incubator for 1 hour at 43°C with 5% CO2. Arsenic 
treatment was performed by incubating cells with media containing Arsenic (500µM) for 
1 hour at 37°C with 5% CO2. To avoid activation of HS -responsive genes due to addition 
of fresh media to the cells (Mahat 2016), fresh media was added 24 hours prior to the 
treatment. 
 A549 human lung adenocarcinoma cells were obtained from American Type 
Culture Collection (ATCC). Cells were cultured in RPMI-1640 (Life Technologies) media 
supplemented with 10% fetal bovine serum (FBS) (Gibco) at 37°C incubator with 5% CO2. 
Cells were treated with 10ng IL-1b (Sigma – I 9041) for 15 minutes, 30 minutes, 
45 minutes, 60 minutes, 120 minutes, and 5 hours, and compared with untreated cells.
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 NMuMG mouse mammary gland cells were obtained from American Type Culture 
Collection (ATCC). Cells were cultured in DMEM/F12 (Life Technologies) media 
supplemented with 10% fetal bovine serum (FBS) (Gibco) at 37°C incubator with 5% CO2. 
They were used as spike-in controls for normalizing sequencing data from human cells. 
2.2  Reverse Transcription Quantitative PCR (RT-qPCR) Gene Expression Analysis 
 Total RNA was extracted from cells using Qiashredder (Qiagen) and RNeasy kit 
(Qiagen) and checked for integrity using agarose gel electrophoresis. Total RNA 
concentration was measured using Nanodrop. 500ng -1µg of RNA was used to synthesize 
cDNA using random hexamer primers and SSRTIII reverse transcriptase enzyme (Life 
Technologies). Two-step real-time PCR was performed on these samples using primers 
self-validated and IDT-validated primers. Data were normalized against ACTB and 
GAPDH gene transcripts. Data were derived from at least two independent biological 
replicates and shown as mean +/- standard deviation. Statistical analysis was done using 
paired t-test (parametric) and one-way ANOVA with 95% confidence level using 
GraphPad Prism.  
 All primers for PCR and RT-qPCR reactions are listed in Table 2.1. 
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Table 2. 1. List of primers used for performing PCR reactions 
Primer name Sequence
KLF6 pre-mRNA F' CTGGCAACAGGTAAACGCAGC
KLF6 pre-mRNA R' AGGCCCAGCGGACCGCA
ACTB pre-mRNA F' CGCCGCCAGGTAAGCCCG



















hSnai1 + 29F AGTGGTTCTTCTGCGCTACTGCT
hSnai1 + 139R TCGCTGTAGTTAGGCTTCCGATTG
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2.3  RNA-Sequencing 
 Total RNA was extracted from untreated cells and 5-hour IL-1b treated cells 
followed by RT-qPCR to validate expression of candidate genes using methods as 
previously described. Two independent biological replicates were sent to Novogene for 
library preparation and sequencing. Libraries were synthesized by Novogene with poly-A 
selection specifically enriching for stable RNAs and were sequenced in a paired-end 
manner with a sequencing depth of ~ 29 million reads (Table 2.2). 
Table 2. 2. Table showing the RIN values of RNA samples that were 
sent for sequencing and their respective sequencing depth 
Samples Quality (measured by 
RNA Integrity 
Number or RIN) 
Aligned reads 




A549 IL1b 5h Rep#1 10  31947851 
A549 IL1b 0min 
Rep#2 
10   28998187 
A549 IL1b 5h Rep#2 9.90   29442048 
 
2.4  Precision Run-on Followed by Sequencing (PRO-Sequencing) 
Nuclei isolation 
 Approximately 20 million cells were harvested, and nuclei were extracted using 
lysis buffer (10mM Tris-Cl, pH= 7.5, 2mM MgCl2, 3mM CaCl2, 0.5% IGEPAL, 10% 
glycerol, 2Units/ml Superase-In, Protease Inhibitor Cocktail). Spike-in mouse cells (5%) 
were added to human cells during nuclei extraction for all samples except one. Cells were 
pipetted gently in 3mL of lysis buffer for approximately 15 times using a P-1000 tip with 
the end cut off and incubated on ice for 5 minutes. Cells were centrifuged at 1000g for 10 
minutes at 4°C, supernatant was discarded, and the process was repeated once more. Cell 
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pellet was then washed with 1mL of freezing buffer (50mM Tris-Cl, pH= 8.3, 40% 
Glycerol, 5mM MgCl2, 0.1mM EDTA) and centrifuged using same parameters. 
Supernatant was discarded, and cell pellet was resuspended in ~60µl of freezing buffer 
making the total volume to 100µl and was either stored at -80°C or used for the next step. 
Nuclear run-on reaction 
 In-vitro run on reaction was carried on at 37°C heated water-bath for 3 minutes 
using biotin-labelled nucleotides, 3µl each of biotin-11-ATP (PerkinElmer, cat. no. 
NEL544001EA), biotin-11-CTP (PerkinElmer, cat. no. NEL542001EA), biotin-11-GTP 
(PerkinElmer, cat. no. NEL545001EA), and biotin-11-UTP (PerkinElmer, cat. no. 
NEL543001EA) in a single tube. Total RNA was extracted by adding Trizol LS (Ambion; 
cat. no. 10296028) immediately to stop the run-on reaction and vortexed vigorously. 
Samples were incubated for 5 minutes at room temperature to allow complete dissociation 
of nucleoprotein complexes followed by chloroform (Sigma) extraction. Extracted RNA 
was then heat-denatured at 65°C for 40 seconds and immediately placed on ice. 
RNA fragmentation 
 RNA is fragmented to a size of ~ 100bp by incubating the samples with 1M NaOH 
for 10 minutes on ice. Hydrolyzed samples were then purified using RNase-free P-30 
buffer exchange column (Biorad).  
First bead purification 
 Samples were enriched for biotin-labeled RNA by performing Streptavidin bead 
binding at room temperature for 20 minutes at ~1000 RPM. RNA-bound beads were then 
washed twice with ice cold high salt buffer, twice with binding buffer and once with low 
salt buffer. Bound-RNA was isolated from the beads using Trizol (Ambion) followed by 
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chloroform. Trizol extraction was performed twice on the same beads to maximize the 
amount of RNA obtained from the beads. The aqueous phase from both extractions were 
pulled together and RNA was precipitated by incubating with 100% ethanol and GlycoBlue 
at room temperature for 10 minutes followed by centrifugation at 14,000 RPM for 20 
minutes at 4°C. 
3’ adaptor ligation 
 1µl of 100µM 3’ RNA adaptor was diluted with 3µl of nuclease free water (NEB) 
and was used to dissolve RNA pellet from bead purification step. RNA was again heat-
denatured at 65°C for 40 seconds and immediately placed on ice. 3’ adaptor ligation was 
carried at 20°C for 6 hours and incubated overnight at 4°C with T4 RNA ligase I enzyme 
(NEB), 10mM ATP, 50% PEG and RNase inhibitor Superase-In (Thermo Fisher).  
Second bead purification 
 The samples were brought to 50µl with nuclease free water and a second 
Streptavidin purification for biotin-enriched RNA was performed in a similar fashion, as 
was previously described. 
Decapping of 5’-capped RNAs 
 Bead purified RNA was dissolved in 5µl nuclease free water and heat denatured at 
65°C for 40 seconds and immediately placed on ice. Pyrophosphates were removed from 
5’ end of triphosphorylated biotinylated RNAs using RNA 5’ Pyrophosphohydrolase 
(RppH) enzyme (NEB) and incubating the reaction at 37°C for 1 hour.
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5’-end phosphorylation 
 Decapped RNAs were then subjected to 5’-end phosphorylation by polynucleotide 
(T4-PNK) enzyme (NEB) with 10mM ATP and Superase-In at 37°C for 1 hour. RNA was 
then extracted using Trizol followed by triple chloroform purification. RNA was 
precipitated in 100% ethanol and GlycoBlue. 
5’ adaptor ligation 
 1µl of 100µM 5’ RNA adaptor was diluted with 3µl of nuclease free water (NEB) 
and was used to dissolve 5’ end repaired RNA pellet. RNA was again heat-denatured at 
65°C for 40 seconds and immediately placed on ice. 5’ adaptor ligation was carried at 20°C 
for 6 hours and incubated overnight at 4°C with T4 RNA ligase I enzyme (NEB), 10mM 
ATP, 50% PEG, and RNase inhibitor Superase-In (Thermo Fisher). 
Third bead purification 
 The samples were brought to 50µl with nuclease free water and a third Streptavidin 
purification for biotin-enriched RNA was performed in a similar fashion, as was previously 
described 
Reverse transcription 
 RNA pellet was dissolved in 10µl nuclease free water and cDNA was synthesized 
using 100µM RP1 reverse transcription primer at a final concentration of 2.5 µM and 625 
µM dNTP mix, 0.1M DTT, Superase-In, and reverse transcriptase SSRT III. The mixture 
was incubated at 45°C for 15 minutes, at 50°C for 40 minutes, at 55°C for 10 minutes, and 
at 70°C for 15 minutes. Total volume of samples was brought to 26µl.
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PCR amplification 
 PCR amplification of cDNA templates were performed in real-time using 250 nM 
of each RP1 and RPI-1 primer (IDT), 250 µM dNTP mix, 1x HF buffer, 1M Betaine, 1x 
Evagreen dye, and Phusion DNA polymerase. Amplification curves were observed in real-
time on a Biorad quantitative-PCR machine and reaction was terminated at 1500-2000 
RFU x 103 or relative fluorescence units which is reached approximately in 10 to 13 cycles, 
depending on the samples. 
 In some cases, full-scale PCR amplification cycle numbers were determined by 
taking 2µl of cDNA sample and making dilutions corresponding to 17, 15, 13, and 11 full-
scale PCR cycles. Amplified test cDNA was run on 2.2% agarose gel with Blue DNA 
loading dye in 1X TAE buffer at 100V for 15 minutes and 130V for 45 minutes. The gel 
was stained with either 10µl of Ethidium Bromide or 15µl of SYBR Gold in 150 ml of 1X 
TAE buffer. The gel was stained for 10 minutes and imaged with UV-light. Cycle numbers 
for full-scale amplification were determined where there was sufficient amount of product 
with 50 -75% unused primers (Fig 2.1).  
Library size selection 
 PCR-amplified products were then run on 6% TBE gel (Novex) with 1X Tris-
Borate-EDTA (TBE) buffer with 100bp DNA ladder (NEB) at 120V for 45 minutes. The 
gel is stained with 8µl ethidium bromide in 100ml 1X TBE for 5 minutes with gentle 
shaking. Stained gel is then imaged with UV-light and bands from ~ 125bp-300bp are 
excised with a clean razor (Fig 2.2). Gel fragments are then sheared in gel-braker tubes 
placed in 2 ml eppendorfs. Gel fragments are then dissolved in 400 µl 1X Tris-EDTA (TE) 




Figure 2. 1. Test amplification of PRO-seq samples. 2µl cDNA samples amplified 
using different PCR cycles (17, 15, 13, 11) run on 6% Tris-Borate-
EDTA (TBE) non-denaturing gels to determine the minimum number 
of PCR cycles for amplification of total library. Left: TBE gel with 
unsuccessful libraries showing either too short fragments or no 
enrichment at all. Only unused primers can be seen at the bottom. 
Right: A successful test amplification run on a TBE gel.  
 
fragments are then purified through cellulose-acetate spin filters (Agilent) to get rid of any 
undesired particles. Library is then extracted with 300 mM sodium acetate (Sigma),  








Figure 2. 2.   Size selection by gel purification of PRO-seq library. (Left) Fully 
amplified library (after PCR cycle number determination) run on 6% 
TBE non- denaturing gel. (Right) Size selection using gel purification 
 
Sequencing 
 Samples were first quality-controlled on a BioAnalyzer and fragment sizes from 
libraries were validated to be within the range of expectation (Fig 2.3).  
 They were further quality-controlled by running on a MiSeq sequencer generating  
~ 3 million paired-end reads. If the sample showed biological difference among different 
time points of treatments and similarity among replicates, they were sent to Novogene for 





Figure 2. 3.  Bioanalyzer image of a successful PRO-seq library showing peak 
around ~150-200bp 
 
2.5  Chromatin Immunoprecipitation Followed by Sequencing (ChIP-seq) 
Crosslinking 
 Approximately 2*107 cells were crosslinked with 1% methanol-free formaldehyde 
(16% formaldehyde solution w/v from Thermo Scientific) in serum-free DMEM/F12 
media rotating in a slow shaker at room temperature for 10min followed by quenching with 
0.125M Glycine. Cells were washed with 1x phosphate-buffered saline (PBS) thrice and 
lysed by incubating on ice with lysis buffer with 1% sodium-dodecyl sulfate (SDS) 
(ingredients) for 15min. 
Sonication 
 Sonication condition was first standardized using different time points (0min, 2min, 
4min, 6min, and 8min) in a Covaris sonicator with 200 cycles per burst, duty factor of 5 
and peak power of 140. Ideal sonication condition was determined by running sonicated 





Figure 2. 4.  DNA was extracted from sonicated samples and were run on a 1.5% 
agarose gel with an unsheared control sample (0 min) with 100bp DNA 
ladder to check size of shearing. From the same sonicated samples, 
protein was extracted and protein-of-interest (eg: HSF1) for ChIP was 
immunoblotted to check integrity (bottom panel). 
 
 Following standardization, all samples were sonicated for 6 min in Covaris 
sonicator using 200 cycles per burst, duty factor of 5 and peak power of 140. Sonicated 
cells were centrifuged at 10,000 RPM for 10 minutes at 4°C to get rid of any debris and 
the supernatant was collected. 2% of the supernatant was collected and validated for 
sonication of chromatin by reverse-crosslinking and extracting DNA and running it on a 
1.5% agarose gel stained with ethidium bromide at 150V with 100bp ladder (NEB). 
Another 2% of supernatant was collected for validation of protein integrity by performing 
Western Blot against candidate proteins.
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Pre-clearance of sonicated samples 
 Magnetic beads A+ G in the ratio 1:1 were washed twice and resuspended in 
dilution buffer. Sonicated samples are pre-cleared with washed magnetic beads A + G for 
1 hour in a slow rotor at 4°C. Beads were removed by placing the tubes on a magnetic stand 
and 1% of the sample were taken as inputs. At least two inputs were taken for each sample.  
Antibody binding 
 Precleared samples were incubated with 5µg of each of the antibodies listed below 
(Table 2.3) in 2ml dilution buffer (1% Triton-X, 2mM EDTA, 20mM Tris pH=8.0, 150mM 
NaCl, 1X PMSF, protease inhibitor) by slow rotation overnight at 4°C.  
Table 2. 3. List of antibodies used for performing ChIP 
experiments 




H3K4me1 Abcam 5µg 
H3K4me3 Abcam 5µg 
Pan H3 Abcam 5µg 
H3K27ac Abcam 5µg 
RNA Pol II CTD CST 5µg 
HSF1 Enzo 5µg 
 
Magnetic bead purification 
 Antibody-bound samples were enriched by incubating with prewashed magnetic 
beads for 2 hours at 4°C in slow rotor. Beads were separated using magnetic stand and 
supernatant containing unbound antibody or chromatin was discarded. Beads were washed 
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once with ice-cold low salt buffer, thrice with ice-cold high salt buffer, once with lithium 
chloride buffer, and twice with TE buffer by slow rotation for 5 minutes at room 
temperature. Beads were resuspended in SDS elution buffer, and chromatin was extracted 
by shaking the solution at 900 RPM for 30 minutes at 65°C.  
DNA Extraction 
 Chromatin is reverse-crosslinked by incubating the samples overnight in 200mM 
sodium chloride at 65°C. Samples were then treated with Proteinase-K for 2 hours at 56°C 
in presence of Tris-Cl (pH=8) (Sigma) followed by phenol-chloroform (Sigma) extraction 
of DNA. DNA was precipitated using 300mM sodium acetate, 1µl GlycoBlue, and 100% 
ethanol. DNA was resuspended in 1x TE buffer and real-time qPCR was performed for 
positive and negative control primers as listed in Table 2.1. 
Library preparation 
 ChIP DNA library was prepared using qPCR-validated samples following 
NEBNext Ultra II DNA library prep kit (NEB) protocol without performing size selection. 
Library was validated using qPCR against positive and negative control primers. Validated 




Figure 2. 5.  ChIP sequencing library run on High-Sensitivity Bioanalyzer Chip for 
detecting the range of fragment distribution and as a quality-control 
step before running on MiSeq 
 
2.6  ATAC-Sequencing 
Cell harvesting 
 Cells were grown in 10cm dishes with complete media supplemented with 5% FBS 
for a day. Cells were harvested by incubating with 2ml of 0.25% of Trypsin for 2-4 minutes. 
Complete media was added to trypsinized cells immediately to stop the reaction and were 
centrifuged at 500 g for 5 minutes. Cell pellet was collected and washed with cold 1X PBS 
by centrifugation.  
Cell Lysis 
 Cells were then resuspended in cold 1X PBS at a concentration of 1x 106 cells/mL. 
5 x 103 cells (~50 µl) were collected and centrifuged. Supernatant was discarded and cells 
were lysed using equal volume (~50 µl) of Greenleaf’s lysis buffer (Tris ph=7.5, MgCl2, 
NaCl, 0.5% IGEPAL) for 5 minutes on ice. Two parallel tubes of cells were lysed together 
using the same protocol – one was used to cell count and rupturing of nuclei after lysis, the 
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other one was used for further processing of ATAC. After lysis, the cells were spun at low 
speed 500 g for 5 minutes at 4°C.  
Transposase reaction and PCR amplification 
 Supernatant was discarded and 50µl transposase reaction mix  
(2x TD buffer = 25µl, Tn5 Transposase = 2.5 µl, Nuclease free water = 22.5 µl) was added. 
Cells were continuously shaken at a low speed of 400 RPM at 37°C for 30 minutes. DNA 
was purified using MinElute Qiagen kit and amplified using NEB Nextera kit using our 
modified real-time PCR protocol.  
2.7  Western Blot 
 Cells were lysed in Urea lysis buffer (8M Urea, 1% SDS, 126mM Tris pH 6.8) and 
protein concentration was measured in Qubit 1.0 fluorometer using Qubit protein assay kit 
(Invitrogen). Cell lysates corresponding to ~ 30ug of protein were run on a 10% SDS-
PAGE resolving gel (BioRad) at 200V for 1 hour followed by transfer of protein from gel 
unto a polyvinyl fluoride or PVDF membrane in 1x transfer buffer (100ml of 10X Tris-
Glycine-SDS and 200ml of methanol in 700ml Miili-Q water) for 2 hours at a constant 
current of 100V at 4°C. Non-specific antibody binding sites were blocked by incubating 
the blots in 5% milk diluted in 1x TBS with 0.1% tween (TBS-T) for 30 minutes. Blots 
were washed thrice for 5 minutes with vigorous shaking at room temperature and incubated 
with primary antibody as listed in Table 2.4 at concentration validated by the manufacturer 
or in our lab overnight at 4°C on a slow rotator. The blots were washed with 1x TBS-T 
three times for 10 minutes each. The blots were incubated with secondary antibody 
conjugated to horse-radish peroxidase (HRP) (GE) at a dilution of 1:10,000 or 1:5000 
respectively for 1 hour at room temperature on a slow rotator. Blots were washed with 1x 
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TBST three times for ten minutes each and either imaged directly on an Odyssey imager 
using the appropriate absorbance spectrum of the respective fluorophore or incubated with 
chemiluminescent HRP substrate (Amersham ECL GE) and imaged on an Odyssey imager, 
respectively. 






































HSF1 Enzo 1:1000 Anti-rabbit 
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GE 




2.8  Bioinformatic Analysis 
2.8.1.  RNA-Seq Analysis  
 Libraries were aligned against hg19 human genome with HISAT2 alignment tool. 
Libraries were converted to BAM format using SAM tools and differential gene expression 
was analyzed with DESeq2 program performed on R with a p value of 0.01. 
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2.9  ChIP-Seq Analysis 
 Libraries were aligned to human hg19 genome using HISAT2 and bam files were 
generated. Bam files were converted to BigWig files using bamCoverage with the default 
bin size of 50bp. These files were uploaded to UCSC Genome Browser for visualization.  
 Duplicate reads from aligned bam files were removed using picard tools ‘mark 
duplicates’ where duplicate reads are defined as arising from the same DNA fragment with 
same 5’ end. After detecting the duplicate reads, picard assigns scores to each of the reads 
based on the sum of their base quality and differentiates between primary and duplicated 
reads.  
 Peaks were called independently in each sample using MACS2 peak calling 
software with a q-value or FDR cut-off of 0.01 selecting for only strong peaks. 
Furthermore, only those peaks are selected for further analysis which were found to be 
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present in both replicates of the library. However, for some analysis, all called peaks from 
all samples were used. 
Heatmaps and metaplots were generated using deepTools plotHeatmap and plotMetaplot 
function with BigWig files normalized internally using Counts Per Million (CPM) reads.  
 MACS2 narrow peak files were converted into genomic ranges (Granges) object 
and peaks were annotated using BioConductor package ‘ChIPseeker’ in R. Overlap of 
peaks among replicates were also performed using ‘ChIPseeker’ package function 
‘findOverlapofPeaks’ with a maximum distance of 1000bp.  
 Motif analysis was done using HOMER tool ‘findMotifsGenome’ and size of 
region specified for motif search was 200, which was also the recommended size for motif 
analysis by HOMER. 
2.10  ATAC-Seq Analysis 
 Adapters were trimmed from fastq reads of ATAC libraries using ‘trimmomatic’. 
Reads were then aligned to human hg19 genome using HISAT2 and bam files were 
generated. Bam files were converted to BigWig files using bamCoverage with the default 
bin size of 50bp. These files were uploaded to UCSC Genome Browser for visualization.  
 Duplicate reads from aligned bam files were removed using picard tools ‘mark 
duplicates’ where duplicate reads are defined as arising from the same DNA fragment with 
same 5’ end. After detecting the duplicate reads, picard assigns scores to each of the reads 
based on the sum of their base quality and differentiates between primary and duplicated 
reads.  
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 Peaks were called independently in each sample using MACS2 peak calling 
software with a q-value or FDR cut-off of 0.01 selecting for only strong peaks. 
Furthermore, only those peaks are selected for further analysis which were found to be 
present in both replicates of the library. However, for some analysis, all called peaks from 
all samples were used. 
 Heatmaps and metaplots were generated using deepTools plotHeatmap and 
plotMetaplot function with BigWig files normalized internally using Counts Per Million 
(CPM) reads.  
 MACS2 narrow peak files were converted into genomic ranges (Granges) object 
and peaks were annotated using BioConductor package ‘ChIPseeker’ in R. Overlap of 
peaks among replicates were also performed using ‘ChIPseeker’ package function 
‘findOverlapofPeaks’ with a maximum distance of 1000bp.  
2.11  PRO-Seq Analysis 
 Adapters (sequence = TGGAATTCTCGGGTGCCAAGG) were removed from 
PRO-seq libraries using ‘cutadapt’ and reads shorter than 15 bp in length were discarded. 
Trimmed reads were aligned against human ribosomal RNA (rRNA) to get rid of rRNA 
contamination of nascent transcripts and filtered reads were used for further processing. 
For generating rRNA index assembly, 42,999 bp linear human ribosomal DNA sequence 
was obtained from GenBank: U13369.1, NCBI and indexed using ‘bowtie-build’. 
Unaligned rRNA reads were now aligned against human hg19 using HISAT2 and BAM 
files were generated. BigWig files were generated from BAM files and uploaded on UCSC 
Browser for visualization. 
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 These BigWig files were normalized using multiple ways to rule out technical 
effects from the data. The files were normalized against –  
a) read depth of spike-in control from mouse nuclei 
b) 3’ end of long genes where Pol II could not have reached within the time of 
treatment if it progressed at 3kb/min. If treatments were 60 minutes long, the region 
of genes selected for normalization was from (60 minutes *3kb) 180kb plus 20kb 
buffer region to 0.5kb before the gene ends to avoid the polyA tail. 
c) Counts per million (CPM) 
 Heatmaps and metaplots were generated using deepTools plotHeatmap and 
plotMetaplot function with normalized BigWig files. 
 Differential changes in gene expression was done using DESeq2 with a p-value cut-
off of 0.05 on gene bodies. Gene body was defined as TSS +200bp to +120kb. 
 Pathway analyses of differentially regulated genes were done using Bioconductor 
packages ‘ChIPseeker’ and ‘clusterProfiler’. 
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CHAPTER 3 
GLOBAL HEAT SHOCK RESPONSE IS CELL-TYPE SPECIFIC AND 
REVEALS DISTINCT CHANGES AT INTERGENIC REGIONS OF CELLS, 
INDEPENDENT OF HEAT STRESS 
 
3.1  The Heat Shock Response (HSR) 
 Life has been found to prosper in a diverse range of temperatures from below 
freezing point to as high as 113°C (Stetter et al, 2006)96. Temperature plays a huge role in 
sustenance of life including growth and reproduction. Even minor changes in temperature 
can have huge impact on the survival of all living organisms (Stetter et al, 2006)96. Changes 
in temperature such as exposure to high heat can cause denaturation of proteins, abnormal 
protein folding, accumulation of abnormal proteins resulting in proteotoxic stress and loss 
of cellular homeostasis in living organisms 97. In eukaryotic cells, heat stress not only 
affects individual proteins but leads to major changes in subcellular components including 
actin filaments, endoplasmic reticulum, mitochondrial structures and lysosomal 
compartments within the cell 97 (Richter, 2010). Thus, even slight increases in temperature 
can lead to death of organisms. Therefore, cells have evolved a very conserved pathway of 
buffering stress response called the heat-shock response or HSR pathway. HSR has been 
found in plants, bacteria, yeast, slime molds, fishes, sea-urchins, flies, and mammals. HSR 
is thus a highly conserved, probably universal mechanism present in most of the organisms 
that have been studied till date98. The temperature at which an organism would mount HSR 
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is specific to the organism itself. For example, E. coli shows HSR at 42°C while HSR in 
salmon is seen at 24°C 98. 
 The effect of heat stress has been shown as early as in 1930s in fruit fly Drosophila 
(Goldschmidt, 1935; cf. Morimoto et al., 1990; Stetter 2006). Flies are normally grown at 
room temperature around 25°C 98 (Lindquist, 1986), however when temperature is raised 
to 29°C flies show HSR, the maximum effect being seen between 36°C and 37°C 98 
(Lindquist, 1986). At 37°C, Drosophila melanogaster show rapid changes in chromosomal 
structures and associated transcription99 (Jamrich, 1977). Active regions of transcription in 
chromosomal puffs of Drosophila salivary gland lose RNA Polymerase stain 99,100 (Ritossa, 
1962; Jamrich, 1977), whereas new sites of transcription appears in the puffs as shown in 
the figure below 99 (Jamrich, 1977) (Fig 3.1) 
 
 
Figure 3. 1  Immunofluorescent images showing polymerases disappear from puffs 
in Drosophila after heat-shock for 45min. Arrows indicate appearance 
of RNA Pol II after heat-shock whereas circles indicate regions from 
where polymerases are removed as a result of heat-shock. Figure reused 






 Studies show that there are approximately seven functional groups of proteins that 
are upregulated in HSR (Fig 3.2)97. However, the members of these groups and the extent 
of upregulation is highly variable among organisms. These group of proteins include: 
1. Hsps or heat-shock proteins such as hsp70, hsp90 that act as molecular chaperones 
2. Proteins involved in proteolysis to clear misfolded and irreversibly aggregated 
proteins 
3. DNA/ RNA repair proteins to correct double-stranded nucleic acid breaks or 
epigenetic mutations such as aberrant methylations 
4. Metabolic enzymes to balance energy supply 
5. Transcription factors and kinases involved in regulating the response itself 
6. Proteins involved in protecting cytoskeletal structures and cell organization 
7. Membrane transport and detoxifying proteins 
 
 
Figure 3. 2.  Summary of the functional classes of genes upregulated during the heat 
shock response in S. cerevisiae after an increase in temperature from 
25°C to 35°C for 10 min. Figure taken from Richter et al., Molecular 
Cell; Volume 40, Issue 222 October 2010Pages 253-266 with 
permission.97 
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3.2  Heat Shock Factors 
 In eukaryotes, heat-shock response proteins are regulated at transcriptional level by 
a class of transcription factors (TF) called heat-shock factors (HSFs) (Wu, 1984) 98. Till 
date, a single HSF has been identified in invertebrates while four HSFs: HSF1, HSF2, 
HSF3 and HSF4 has been identified in vertebrates 101. Among the heat shock factors 
studied, HSF1 is the most well characterized and is found to be the chief activating factor 
for HSR genes such as hsp70 in heat shocked cells. HSF1 is constitutively expressed in 
cells at physiological temperature and is present mostly in the cytosol as an inactive 
monomer. HSF1 forms a complex with hsp70 or hsp90 chaperone proteins which block it 
from being released in unstressed cells. With heat-shock, hsp70 and hsp90 bind denatured 
proteins and release HSF1102. HSF1 gets heavily phosphorylated, homo-trimerized and 
transported to the nucleus where it then binds to heat-shock response elements (HSE) 
present on DNA.103 HSE consists of 3–6 alternating, inverted pentameric repeats (nGAAn). 
HSF1 binds HSEs through a well conserved winged helix-turn-helix DNA binding domain 
101. HSF1 itself has heat-sensing capacity as it can spontaneously trimerize in-vitro with 
heat stress101,104,105,106. Below is a schematic of HSF1 functional domains with their 
respective post-translation modifications from Åkerfelt et al., 2010101 (Fig 3.3). 
 HSF1 protein is composed of 529 amino acids which undergoes several post-
transcriptional modifications (Fig 3.3). At N-terminal of the protein lies the DNA binding 
domain (DBD) which undergoes acetylation (A) by p300. Acetylation of the DBD 
decreases HSF1’s ability to bind to DNA whereas deacetylation by sirtuin SIRT1 increases 
its DNA binding ability. The heptad repeats (HR-A and HR-B) are hydrophobic repeats 




Figure 3. 3.  Schematic diagram of HSF1 protein showing its different binding 
domains. Figure reused from Åkerfelt et al., Nat Rev Mol Cell Biol, 11 
(8), 545-5; 2010 with permission 
 
suppresses spontaneous trimerization of HSF1. The regulatory domain (RD) contains 
phosphorylation-dependent sumoylation motif (PDSM) and undergoes rapid 
phosphorylation (P) and sumoylation (S) upon heat-shock leading to transactivation of 
HSF1. The transactivation domain is composed of two modules — AD1 and AD2, rich in 
hydrophobic and acidic residues, and is responsible for rapid stress response upon. 
 HSF1 is activated not only during heat shock, but also in response to heavy metal 
stress such as arsenic, copper, zinc, cadmium, and silver107. HSF1 is also shown to be 
activated by anti-inflammatory drugs such as Celastrol108. These observations highlight the 
fact that HSR pathway can be activated by both heat-dependent stress and heat-independent 
stress. It has been recently shown in mouse cells that HSR leads to HSF1 binding at and 
outside of promoters103. However, if HSF1-mediated HSR is similar or different between 
heat-dependent and heat-independent stimuli in the same system in terms of HSF1 binding, 
transcriptional output and chromatin accessibility have not been looked at. In my study I 
have dissected the mechanisms of transcriptional responses in two different human cell 
types exposed to heat stress and heat-independent heavy metal stress both of which rapidly 
induce HSR. We also asked if how two human cell lines, of very different origin, both 
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activating HSR pathway in response to heat shock utilize a similar mechanism of 
transcriptional activation upon heat stress. 
3.3  Motivation 
 Because of its importance in basic science as a model of transcription activation 
and its health relevance in diseases such as cancer, HSR has been studied extensively. HSR 
has been shown to be induced by heat-dependent and heat-independent stimuli in normal 
cells as well as HSR can be induced by cancer cells as a protective mechanism to survive 
in the body. We asked whether cells utilize the same program of HSR when exposed to 
temperature-dependent and temperature-independent stresses. We further questioned if 
HSR follows the same program in two different cell types. In this section, I would elucidate 
my findings of HSR across different cell types exposed to heat-dependent and heat-
independent stressors. 
3.4  MCF7 Cells Elicit Robust HSR When Exposed to Heat-Shock (HS) and 
this Response is Transient  
 MCF7 cells were subjected to rapid HS at 43°C (this is a standard HS temperature 
that has been used by several labs through decades) in a time-dependent manner – 0 
minutes, 15 minutes, 40 minutes, 60 minutes, and 180 minutes, and changes in gene 
expression was measured with RT-qPCR against known heat-shock responsive genes such 




Figure 3. 4.  Time-dependent HSR induced by heat-dependent and heat-independent 
stresses. RT-qPCR on heat shock and arsenic treated MCF7 cells (n = 
2, p<0.01) over a time-course showing upregulation of transcription in 
heat-shock responsive genes. Statistical analysis is done using non-
parametric unpaired t-test followed by Mann-Whitney test. 
 
 To determine if exposure to such high temperature causes temporary or permanent 
change in expression of HS responsive genes in MCF7 cells, a HS pulse experiment was 
performed where cells were heat-shocked for 60 minutes at 43°C and then kept at 37°C for 
4 hours. RNA was extracted from these cells and RT-qPCR was performed showing that 
HSR to temperature is transient and normal gene expression level is restored (Fig 3.5). 
3.5  Standardization of ChIP-Sequencing (ChIP-seq) Technique 
 Before proceeding to the major ChIP-seq experiments, we first established the 
protocol of ChIP-seq using RNA Pol II CST antibody. A 1:1 mixture of magnetic Protein 
A and magnetic Protein G beads were used to chromatin bound to Pol II or chromatin 
without Pol II. Increasing concentrations of beads: 1X (15 µl), 2X (30 µl) and 4X (60 µl) 




























































antibody (5 µl). Increasing concentration of beads led to increased pulldown of protein-
bound chromatin but simultaneously decreased signal-to-noise (S/N) ratio. 2X 
concentration of beads were decided to be ideal for further ChIP-seq experiments 
(Table 3.1 and Fig 3.6).  
 
 
Figure 3. 5.  HSR is transient. RT-qPCR (n=1) of HS-responsive genes in MCF7 
cells showing upregulation with heat-shock and return to near basal 
state after removal of heat-stress indicating HSR is rapid and transient. 
 
 
Table 3. 1. Table showing signal-to-noice ratio 
with addition of different concentrations of  
Dynabeads protein A and Dynabeads protein G. 
 
Samples Primers % input S/N
IP_+P2_1X Snail Up 0.0011
Snail Promoter 0.1518 141.2
Snail down 0.0014
IP_-P2_1X Snail Up 0.0008
Snail Promoter 0.0028 3.507
Snail down 0.0002
IP_+P2_2X Snail Up 0.0043
Snail Promoter 0.4648 107.3
Snail down 0.0028
IP_-P2_2X Snail Up 0.0006
Snail Promoter 0.0028 4.611
Snail down 0.0005
IP_+P2_4X Snail Up 0.0069
Snail Promoter 0.6182 89.62
Snail down 0.006
IP_-P2_4X Snail Up 0.0025




Figure 3.6.  Magnetic bead standardization for ChIP-seq. ChIP-qPCR against RNA 
Pol II antibody showing greater pulldown of the antibody with 
increased concentration of bead. 
 
 The starting chromatin concentration was validated using 50µg and 100µg of 
MCF7 chromatin against H3K4me3 antibody (Abcam). Chromatin concentration was 
measured by reverse-crosslinking and extracting DNA from sonicated cells. Higher 
concentration of chromatin showed improved signal-to-noise ratio and 100µg chromatin 
was used for further ChIP experiments (Table 3.2). For transcription factor HSF1, 
approximately ~150µg of chromatin was used. 
Table 3. 2. Table showing signal-to-noise (S/N) ratio increases by increasing starting 

















































































































Primer NHS (% Input) HS (% Input) S/N: NHS S/N: HS
Batch1 (100ug) PGBD2 negative control 0.01 0.03
PGBD2 positive control 1.74 2.26 118.94 65.98
SH3BP5L negative control 0.06 0.10
SH3BP5L positive control 2.67 2.76 48.10 28.46
Batch 2 (50ug) PGBD2 negative control 0.05 0.10
PGBD2 positive control 1.39 1.55 26.47 16.33
SH3BP5L negative control 0.10 0.09
SH3BP5L positive control 2.69 2.19 26.10 23.60
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3.6   Genome-Wide HSF1 Binding is a Better Indicator of Heat Shock Response  
than Gene Transcription 
 Previous studies show that binding of HSF1 in response to heat shock (HS) in 
mammalian cells occurs throughout the genome at and outside of gene promoters (Mahat 
et al., 2016). The binding occurs only at a small proportion of potential sequences in the 
genome predicted through analyzing HSF1 sequence motifs. This raises a possibility that, 
rather than being invariant, the pattern of HSF1 binding may be flexible. To determine 
whether HSF1 binding is a function of the stress, we sought to find HSF1 binding in MCF7 
cells treated with rapid HS (heat-dependent) and As (heat-independent). We treated MCF7 
breast cancer cells with HS at 43°C for 60 minutes and performed ChIP-seq against HSF1, 
Pol II and promoter-associated histone mark H3K4me3 in heat-shocked and non-heat-
shocked cells to investigate which of these factors are most sensitive to heat stress. We 
found that upon HS, MCF7 cells do not show dramatic changes in the promoter-associated 
histone marks or in their Pol II level (Fig 3.7A). However, HSF1 shows dramatic changes 
in their distribution. In contrast, massive binding of HSF1 occurs at the promoters of HS-
response genes such as HSPH1 which generates Pol II wave along the gene (Fig 3.7C). We 
confirm, as previously reported in other mammalian cells, that there is a massive genome-
wide HSF1 binding occurring both at distal regions and at promoters. (Fig 3.7B and 3.7D) 





Figure 3. 7.  HSF1 is more sensitive to HSR than transcription.  
(A) Heatmaps showing Pol II, H3K4me3 and PRO-seq signal intensity 
at promoter showing no dramatic difference before or after HS.  
(B) Heatmap of HSF1 peaks at promoter and distal intergenic region 
showing rapid binding of HSF1 to DNA with HS treatment.  
(C) UCSC Browser shot of a HS-responsive gene HSPH1 showing 
promoter-binding of HSF1 and rapid upregulation of transcription.  
(D) UCSC Browser shot of an intergenic region showing massive 
binding of HSF1 but no change in Pol II status or other histone marks 
 
3.7 HS Core Responsive Genes Such as hsp70 or HSPH1 Show Decrease in 
H3K4me3 Peaks at their Promoters at High Temperature 
 Previous studies in yeast and in Drosophila have shown that hsp70 promoter loses 
H3K4me3 when subjected to HS109,110,111. However, promoter dynamics of nucleosomes 
in mammalian cells in response to stresses have not been looked at. ChIP-qPCR was 
performed against promoter and non-promoter regions of HS-responsive genes and control, 



























































































































































HS responsive genes such as hsp70 whereas H3K4me3 at promoters of HS non-responsive 
genes such as ZNF692 and SH3BP5L (referred to as ZNF and SH3 respectively, in Fig 3.8 
C) remained unchanged (Fig 3.8).  
 
 
Figure 3. 8.  H3K4me3 level decreases with HS only at HS-responsive genes. (A) 
Schematic representation of the approximate location of the primers 
used for ChIP-qPCR. (B) ChIP-qPCR against H3K4me3 showing 
decrease in the mark with HS at HS-responsive HSPA1B and HSPH1. 
(C) ChIP-qPCR against H3K4me3 showing no change of histone marks 
with HS at HS non-responsive genes 
 
 We did not observe any massive loss of total (pan) H3 at the promoters of HS-
responsive gene with ChIP-qPCR against pan-H3 (Abcam) probably meaning that 
H3K4me3 mark is getting replaced by other marks such as H3K27ac. Interestingly, we saw 
gain of pan H3 mark at both upstream region and promoter regions of HS non-responsive 
gene. It would be interesting to see if any repressive histone modifications are added to 
gene-promoters of HS non-responsive genes making sure that these genes are not activated 
during HSR (Fig 3.9). 
Primer locations 5’ 3’DownPromoter Gene BodyUp







































































Figure 3. 9.  Pan H3 level unchanged with HS. ChIP-qPCR (n=1) against pan H3 
showing no major changes with HS at HS-responsive genes; however, 
HS non-responsive genes show an increase in pan H3. 
 
 We next asked if this decrease of H3K4me3 at promoters is linked to HSF1 binding. 
We divided HS-responsive upregulated genes into two groups – HSF1 dependent (363 
genes) (Fig 3.10A) and HSF1-independent (374 genes) (Fig 3.10B) based on overlap of 
HS upregulated genes with HSF1 bound peaks at TSS +/-1kb. As expected, we found a 
slight dip at exactly the TSS of HSF1-dependent upregulated genes (Fig 3.10A) whereas 
HSF1-independent upregulated genes showed no changes at their TSS (Fig 3.10B). This is 








































Figure 3. 10.  HSF1-dependent genes show decreased H3K4me3 at promoter with 
HS. Profile of H3K4me3 level of HSF1-dependent (A) showing slight 
dip at promoter with HS and (B) HSF1-independent HSR genes 





Figure 3. 11.  UCSC (University of California-Santa Cruz) Browser showing profile 
of HSR gene HSPH1 (left) and HS non-responsive gene ZNF692 

































3.8  HS Core Responsive Genes Acquire H3K27ac Activation Mark  
 Transcriptionally active genes are often found to be marked by histone 3 lysine 27 
acetylation (H3K27ac) mark. To investigate whether HS-responsive genes also contain 
H3K27ac modification at their promoters, ChIP-qPCR against HS responsive (Fig 3.12; 
left) and HS non-responsive genes (Fig 3.12; right) were performed. Surprisingly, we found 
promoters of HS-responsive genes have low H3K27ac at non heat shock (NHS) condition. 
Upon HS, these genes acquire H3K27ac mark whereas genes that do not respond to HS 
lose this mark. This is an interesting finding which might suggest that cells maintain a 
constant pool of histone code ‘writers’ and during rapid transcriptional response these 
writers are immediately redistributed from non-responsive genes to the activated genes. 
 
Figure 3. 12.  Increase in H3K27ac enrichment at HSR genes. ChIP-qPCR against 
H3K27ac against HSR genes (left) and HS non-responsive genes (right) 
showing HSR acquire transcription-activation mark whereas HS non-
responsive genes lose activation mark upon HS. 
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 Active genes at ground state are marked by higher level of H3K4me3 than inactive 
genes. We categorized genes from NHS PRO-seq data into expressed and non-expressed 
genes based on their relative read counts at the promoter. We took genes that are present 
in both of our independent biological replicates at NHS and defined ‘expressed genes’ 
(which includes both active and poised genes) as genes with absolute value for promoter 
counts more than 10 and ‘non-expressed genes’ as genes with absolute value for promoter 
counts less than 10. We then measured H3K4me3 level at these genes’ promoters and found 
that expressed genes have a much higher level of H3K4me3 at basal condition than the 
non-expressed ones. This observation supports the notion that H3K4me3 modification 
marks only transcriptionally active or poised genes (Fig 3.13). This result also shows that 
majority of the already active genes at ground state do not exhibit a proportional increase 
or decrease in H3K4me3 mark with HSR, indicating that H3K4me3 marks are stable and 
do not undergo rapid changes (Fig 3.13).  
3.9  MCF7 Cells Elicit Robust HSR when Exposed to Arsenic (As) 
 Arsenic is a metalloid that is found in soil, air and water in low amount. Chronic 
exposure to arsenic can lead to cancer whereas arsenic has also been used as drug in treating 
acute promyelocytic leukemia (AML). Sodium arsenite, a trivalent inorganic form of 
Arsenic, causes HSR in mammalian cells and triggers HSF1 pathway. 
 Similar to HS, MCF7 cells were treated with 500 µM sodium meta-arsenite (a 
compound of arsenic) (Sigma S7400) for 0 minutes, 15 minutes, 40 minutes, 60 minutes, 
and 180 minutes, and changes in gene expression was measured with RT-qPCR against the 
same genes as those used for validating HS (Fig 3.3). Response to Arsenic was further 
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validated by performing a dose-curve using 0 µM, 100 µM, 200 µM and 500 µM of Arsenic 




Figure 3. 13.  H3K4me3 is a marker of active genes at ground state in MCF7 cells. 
Heatmap against H3K4me3 showing there is much less binding of 
H3K4me3 at inactive genes (left) than active genes (right) at 
ground/basal state; although this H3K4me3 state remains mostly 
unaffected genome-wide after HS. 
60 
 
Figure 3. 14.  Dose-response curve of As in MCF7 Cells. RT-qPCR showing 
increased dose of As elicits a robust HSR within 60 min. 
 
3.10  Genome-Wide HSF1 Binding Follows an HSR Program  
Independent of Temperature 
 We wondered if HSR induced by a temperature-independent stimulus would follow 
the same pattern as temperature-induced HSR. We exposed MCF7 cells to 500 µM of 
sodium arsenite for 60 minutes which is the exact time we exposed cells to heat stress. We 
validated that the response of MCF7 to arsenic (As) is similar to heat-shock by RT-qPCR 
in terms of fold activation and timing of response (Fig 3.15A). Following validation of HS 
and As treatment conditions, we then performed ChIP-seq against HSF1 and Pol II in 
Arsenic treated MCF7 cells, and compared HSR between these heat-dependent and heat-
independent stresses (Fig 3.15B). HSF1 showed robust binding to DNA both in HS and As 
with ~ 95% of peaks newly appearing in either treatment condition compared to NHS 
condition. As, similar to HS, induces HSF1 binding to promoters of HS-responsive genes 
and activates their expression. We found that a majority (~ 61%) of HSF1 peaks induced 
in response to HS or As are common between these two treatments (Fig 3.15C). We then 
plotted heatmap taking HSF1 peaks common to both HS and As, and HSF1 peaks 
appearing either in HS or As condition (Fig 3.15D). Surprisingly we found that peaks called 




























Figure 3. 15.  MCF7 cells follow an HSR program that is independent of heat.  
A. RT-qPCR showing MCF7 elicits HSR to heat-independent stress 
As, similar to HS.  
B. ChIP-qPCR against Pol II and HSF1 showing enrichment of both at 
HS-responsive gene promoter and negative control regions show no 
enrichment.  
C. Overlap of HSF1 bound peaks at NHS, HS and As state showing 
majority of the peaks overlap within the conditions.  
D. Heatmap of the HSF1-bound peaks showing peaks called 
exclusively in HS are also present in As, and vice versa indication the 
similarity of the HSR program between the two treatments. 
 
unique peaks called might be artefacts of the peak calling software rather than indicating 
biological differences. Furthermore, we found that 88% of the peaks called at NHS 
condition are present in both HS and As indicating HSF1 binding regions might be 
predetermined in a cell type and remain invariant in heat-dependent or heat-independent 
stresses; with exposure to stresses it is the same program that gets amplified.
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 To further validate similarity between HS and As induced HSR, we plotted 
Spearman correlation among NHS, HS and As Pol II (Fig 3.16; left) and HSF1 (Fig 3.16; 
right) samples, respectively and as expected, we found high correlation among the 
treatments and the replicates.   
 
 
Figure 3. 16.  HSF1 and Pol II ChIP-seq samples are highly correlated among 
different conditions in MCF7 cells. Spearman correlation of HSF1 
(left) and Pol II (right) indicated in the squares show similarity in HSR 
program between different conditions 
 
3.11  Genome-Wide HSF1 Binding Follows Cell-Type Specific Programs 
 To understand if HSR follows the same program even across cell-type as it does for 
heat-dependent and heat-independent stresses, we compared HSR in MCF7 breast cancer 
cells to K562 chronic myeloid leukemia cells. K562 cells have been previously used for 
studying HSR and is known to induce robust HSR upon heat stress. We found that both 
cell lines exposed to HS and As induce phosphorylation of HSF1 (Fig 3.17A). We 
performed ChIP-seq against HSF1 and Pol II in HS and As-treated K562 cells. Comparison 
of HSF1 peaks between MCF7 and K562 in these two conditions clearly shows there is a 
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difference in genome-wide HSF1 distribution between the two cell types exposed to the 
same stresses (Fig 3.17 A). However, both cell types induce similar HSR programs in either 
HS or As. Principal component analysis of the two cell types under NHS, HS and As 
induction points out cell type specific clustering rather than treatment-specific clustering 
(Fig 3.17B). Correlation analyses of HSF1 signal in peaks between cell types strongly 
support the cell-specificity of HSF1 distribution; when HSF1 peaks between HS and As 
are compared in any of the cell type, Spearman R is more than 50% in both cases. However, 
when we compare MCF7 versus K562 for the same treatment (either HS or As) Spearman 
R is below 40% (Fig 3.17 C&D).  
 
 
Figure 3.17.  HSR is cell specific.  
(A) showing distinct HSF1 enriched regions in MCF7 HS or As treated 
versus K562 HS- or As-treated cells.  
(B) Principal component analysis (PCA) plots showing cell types 
cluster together irrespective of the treatment for HSF1 ChIP-seq. 
(C & D) Spearman correlation plotted in log10 scale showing 
difference between cell-type for a particular treatment (C) is greater 
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3.12  ChIP-seq Results Against HSF1 is not an Artefact of the Antibody Used 
Mendillo et al., 2012 had reported that in several cancer cell lines HSF1 follows a cancer-
specific heat-shock program which occurs at basal state without HS induction and is 
different from heat-dependent heat-shock program. They generated ChIP-seq data against 
polyclonal HSF1 antibody from SantaCruz in several cell types and primary cells including 
MCF7 at NHS condition. However, the antibody has been discontinued by the 
manufacturer. We first titrated the newly available monoclonal HSF1 antibody from 
SantaCruz with polyclonal HSF1 from Enzo with MCF7 cells treated with Arsenic. We 
validated the result with ChIP-qPCR with both antibodies. SantaCruz antibody yielded 
poor pulldown of chromatin but with Enzo successful pulldown of HSF1 was achieved 
(Fig 3.18). Enzo antibody was used for further HSF1 ChIP experiments.  
 
 
Figure 3.18.  Standardization of HSF1 antibody: monoclonal versus polyclonal. ChIP 
qPCR against HSF1 in MCF7 As treated cells using monoclonal 
SantaCruz antibody (left) resulted in lesser enrichment than polyclonal 

















































 To confirm that pull-down with HSF1 antibodies from SantaCruz versus Enzo is 
not a technical consequence of the ChIP-seq protocol, we performed ChIP qPCR with Pol 
II control antibody which we had already validated before (Fig 3.19). 
 
 
Figure 3.19.  Validation of ChIP protocol during HSF1 antibody test: ChIP-qPCR 
against previously validated Pol II antibody showed enrichment of Pol 
II with As treatment thus validating the ChIP protocol 
 
 To confirm that DNA binding by HSF1 is not an artefact of the specific antibody, 
published HSF1 ChIP seq data were downloaded from GEO database (Table 3.3) and 
analyzed using the same bioinformatic pipeline as our data. 
Table 3. 3  Downloaded ChIP-seq data from NCBI database with their accession number, 
sample IDs and references.
 
 
 Spearman R gives a correlation of more than 70% between HSF1 peaks found in 
our ChIP-seq data and in MCF7 NHS samples generated by Mendillo et al., when both data 
are processed by us using the same parameters. (Fig 3.20; left). These peaks are similar to 

























Figure 3.20.  MCF7 NHS HSF1 ChIP-seq data have high correlation with published 
ChIP-seq data. Heatmap with spearman correlation values in small 
squares between our NHS HSF1 ChIP-seq and published NHS HSF1 
ChIP-seq in MCF7 cells showing high correlation among the samples 
(left). Overlap of peaks called in published HSF1 ChIP-seq data and 
our ChIP-seq data show more than 50% overlap of called peaks. 
 
 We have unpublished ChIP-seq data against old SantaCruz HSF1 antibody which 
we re-analyzed using the same pipeline and showed a correlation of ~ 50% with our data 
with Enzo antibody (Fig 3.21 right) and majority of HSF1 peaks overlapped in NHS and 
HS condition of MCF7 cells (Fig 3.21 left ).  
 We further plotted heatmaps using peaks that were called in both datasets and 
confirmed that peak location is similar with both antibodies (Fig 3.22) in the same cell type 
MCF7. 
 For validation of K562 HSF1 ChIP-seq data, we downloaded previously published 
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Figure 3.21.  New polyclonal HSF1 Enzo antibody shows good correlation with old 
polyclonal HSF1 SantaCruz antibody. Heatmap with spearman 
correlation values in small squares between old and new HSF1 
antibodies in MCF7 NHS and HS samples (left). Venn diagrams 





Figure 3.22.  HSF1 enrichment at similar genomic regions detected by both SCBT 
and Enzo antibodies. Heatmap showing HSF1 ChIP-seq signal at NHS 
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pipeline we used for our K562 HSF1 ChIP-seq analysis. Approximately 50% correlation 
was found with Spearman statistical analysis between published data and our samples with 
majority of the HSF1 peaks common between both samples (Fig 3.23) 
 
 
Figure 3.23.  HSF1 enrichment between published K562 ChIP-seq data and our 
K562 ChIP-seq data is well correlated. Heatmap with spearman 
correlation values in small squares between published and our HSF1 
ChIP-seq in K562 NHS and HS samples (left) show ~50% correlation. 
Venn diagrams showing 66% of NHS peaks and 95% of HS peaks 
overlap with each other (right). 
 
3.13  HSF1 is Enriched at Promoters in Both Treatments in Both Cell Lines 
 As defined using UCSC hg19 database, promoters comprise ~2.35% of the total 
human genome. Though HSF1 binds extensively throughout the genome, in both MCF7 
and K562, HSF1 binding nevertheless shows enrichment at promoters over non-promoter 
regions. In heat-shock, 16% and 10% of total HSF1 peaks are bound to promoters in MCF7 
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promoters in MCF7 and K562 respectively. These observations are consistent with 
previous studies in other cell types (Mahat et al., 2016; Vihervaara et al., 2013) 
demonstrating preference of HSF1 for promoters. Majority of the remaining HSF1 peaks 
are found at intergenic regions, suggesting that HSF1 might bind strongly to enhancers and 
can regulate gene expression from promoter-distal regions (Fig 3.24) 
 
Figure 3.24.  Binding affinity of HSF1 to different genomic regions. HSF1 has a 
strong binding affinity towards gene promoters, although majority of 
the HSF1 peaks appear at intergenic regions. 
 
3.14  Differences in HSF1 Peaks between MCF7 and K562 Arise from  
Distal Intergenic Regions of the Human Genome 
 The differences in location and intensity of HSF1 peaks led us to ask where the 
differences are coming from. As we have previously shown, binding of HSF1 in response 
to both treatments occurs not only at promoters but throughout the genome. We therefore 
annotated promoter-proximal (within 1kb of TSS) and promoter-distal peaks (outside TSS 
+/-3kb) and found both for HS and As treatments, peaks that are closer to promoters 
overlap more between cell types versus peaks that are distal to promoters (Fig 3.25). 
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Figure 3.25.  Variations in HSF1 distribution between cell type arise from promoter-
distal regions. Venn diagrams showing overlap of promoter and distal 
region in HS (left) and As (right) between MCF7 and K562 reveal 
differences in intergenic HSF1 binding are more prominent than 
differences in HSF1 binding to gene promoters. 
 
 To detect correlation between HSF1 peaks that were present at NHS versus HSF1 
peaks present at HS or As in both cell lines, we calculated Spearman correlation based on 
the signal generated from bins pertaining to all called peaks present in all replicates and all 
conditions using deepTools multibigWigsummary and GraphPad PRISM software. We 
found that in both treatments, MCF7 has a higher correlation between NHS and HS peaks 
than K562 (Fig 3.26). These results probably indicate that with stress, K562 gains new 
HSF1 peaks whereas in MCF7, HSR is only amplification of signal already present at 
ground state.  
 We further dissected these correlation plots into changed and unchanged HSF1 
peaks by taking a cut-off value derived from the average signal from peaks that appear at 
the tip of ‘narwhal’s tusk’. Peaks that fell below this cut-off were designated as unchanged 
HSF1 peaks whereas peaks that were above the cut-off were designated as changed HSF1 
peaks. Principal component analyses of these changed (Fig 3.27A) and unchanged HSF1 
peaks (Fig 3.27B) show that peaks that change or do not change with stress cluster together 





Figure 3.26.  MCF7 HSF1 peaks gained as a result of HSR have a higher correlation 
to ground state HSF1 peaks than K562. (A) Scatter plot distribution of 
NHS vs HS HSF1 peaks in MCF7 and K562 with their Spearman 
correlation co-efficient. (B) Scatter plot distribution of NHS vs As 
HSF1 peaks in MCF7 and K562 with their Spearman correlation co-
efficient. 
 
 To find if HSF1 is binding to different motifs in these two cell types, we did 
HOMER motif analyses on NHS, HS and As conditions of MCF7 and K562 cells and 
found, as observed before, HSF1 binding is very specific and binds to its consensus motif 
in all these conditions (Fig 3.28). Hence, the HSF1-binding motif or the DNA sequence is 




























































































































Figure 3.27.  HS non-responsive HSF1 peaks are more specific to cell type than HS 
responsive HSF1 peaks. PCA plot showing both changed (A) and 





Figure 3.28.  HSF1 binding is highly specific. Percentages of HSF1 motif 
occurrences in MCF7 and K562 cells under different stresses (A). 
HSF1 motif sequences found in our ChIP-seq data (B) 
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3.15  Chromatin Openness is not the Major Determining Factor for HSF1 Binding 
 We next asked how does HSF1 specifically bind to only 1% of its target sites and 
whether its binding sites are different among different cell types. We next hypothesized 
that the differences in HSF1 binding in these two cell types might be due to difference in 
chromatin openness between the two cell lines in response to stresses. To test this 
hypothesis, we performed ATAC-seq on HS and As treated MCF7 and K562 cells. 
Spearman correlation was greater than 50% among different conditions in the same cell 
type (Fig 3.29).   
 Surprisingly we found that only minority of the ATAC seq peaks overlap with 
HSF1-bound peaks in both cell lines under both treatments (Fig 3.30).  
 We further isolated peaks that occur at promoter (+/- 1kb) and overlapped HSF1 
and ATAC peaks for MCF7 cells but only a minority of peaks were at the same location 
between each other (Fig 3.31). 
 We wondered if we were unable to determine overlap between HSF1 and ATAC 
peaks because of not selecting the correct distance (“maxgap” parameter in 
findOverlapsofPeaks package) for overlap. To negate that possibility, we randomly 
selected a sample (K562 As ATAC versus K562 As HSF1) and mapped overlap over a 
range of distance from peaks that are 100 bp apart to peaks that are 100,000 bp apart. 
Interestingly, increasing the range of overlap did not result in substantial increase in 
overlapping peaks, indicating that ATAC signal and HSF1 binding are probably 




Figure 3.29.  ATAC-seq libraries in different treatment conditions show high 
correlation in same cell-type. Heatmap with spearman correlation 




Figure 3.30.  HSF1 peaks do not overlap with ATAC-seq peaks. Venn diagram 
between HSF1 peaks and ATAC-seq peaks in MCF7 (A) and K562 (B) 






Figure 3.31.  DNA accessibility is not a major determining factor for HSF1 binding. 
peak overlap between HSF1 peaks do not overlap with ATAC-seq 
peaks. Venn diagram between HSF1 peaks and ATAC-seq peaks in 
MCF7 in different treatment conditions showing even promoter peaks 







Figure 3.32.  Decreasing overlapping distance criteria (maxgap) do not increase 
HSF1 and ATAC-peak overlap. Graph showing no relation between 
ATAC and HSF1 peaks, even when maximum gap between peaks is 
increased to 1,50,000. 
 
 To further validate this observation, published data (Vihervaara et al., 2017) on 
predicted genome-wide HSF1 binding sites in K562 NHS and HS conditions were 
downloaded, analyzed, and overlapped with our ATAC seq data and HSF1 ChIP-seq data 
from K562 NHS and HS. There is an overlap of 95% between our ChIP-seq data and their 
predicted HSF1 binding data (Fig 3.33; left); and ATAC-seq peaks did not overlap with 
published HSF1 predicted regions (Fig 3.33; right), confirming that HSF1 does not 
preferentially bind to open regions. 
3.16  Chromatin Openness at Intergenic Regions is Distinct in Different Cell Types 
 We next asked if open chromatin regions detected by ATAC are similar between 
the two cell types. We found that MCF7 cells have much more ATAC peaks than K562. 
However, we found at ground state, 72% of ATAC peaks in K562 overlap with that of 
MCF7. When cells are exposed to HS or As, this overlap decreases in both cases to 51% 
and 63% respectively, indicating cell-type specific response to both stresses (Fig 3.34). 



















Figure 3.33.  ATAC-seq peaks do not overlap with published K562 HSF1 binding 
sites (predicted). Venn diagram between HSF1 peaks from NHS and 
HS samples showing 90% overlap with published predicted HSF1 
binding sites in K562 (left); Venn diagram between ATAC peaks from 
NHS and HS samples showing barely any overlap with published 




Figure 3.34.  Overlap in chromatin open regions between two cell types decrease 
with stress. ATAC-seq showing 72% of open chromatin regions in 
K562 are similar to that of MCF7. However, with HS and As there is 
local chromatin changes resulting in decrease of overlapping regions 





 We wondered about the genomic locations of these overlapped peaks versus the 
non-overlapped ATAC peaks. These overlapping and unique peaks for each cell line and 
each condition were annotated and as expected, more than 80% of the overlapped peaks 
came from promoter regions for both stresses whereas unique peaks were more frequently 
found at the distal intergenic regions. These results indicate that potential enhancers in the 
distal intergenic regions might be more cell-type specific and might contribute to determine 
a cell’s identity rather than the promoters (Fig 3.35). 
 
 
Figure 3.35.  Similarity in ATAC-seq peaks between two cell types arise from 
promoters. Barplot showing overlapped regions between two cell types 
belong mostly to promoters (top) while unique peaks in both cell types 
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 We further asked if ATAC peaks show different genome-wide distribution in the 
two cell types as HSF1 peaks. We merged all ATAC peaks that were called in both cell 
types and in all conditions from all replicates and created a master ATAC peaklist. We 
plotted heatmap for each of the individual ATAC samples against these peaklists and found 
there are distinct regions in each cell type that have unique ATAC peaks, similar to what 




Figure 3.36.  ATAC-seq signals are cell-type specific. Heatmap showing distinct 
distribution of ATAC-seq signal between MCF7 and K562 cell types; 




















































































 It is evident from the heatmap that ATAC signals in these two cell types show 
differences in distribution. Notably, the top ~1K peaks in the heatmap are more prominent 
in MCF7 while the bottom ~1K peaks have stronger signals in K562. We annotated these 
peaks that are distinctly different in these two cell types and found the top 1k peaks are 
mostly equally distributed between promoters and distal regions whereas the bottom 1k 
peaks are almost exclusively distal peaks (Fig 3.37). 
 We were curious if these distal intergenic regions contain any enhancers or super-
enhancers. We overlapped these regions with cell-type specific typical enhancers (TE) and 
super-enhancers (SE) downloaded from the latest curated super-enhancer database 
(http://www.licpathway.net/sedb/ ). We found that top 1k peaks are more enriched in 
MCF7 cell-specific enhancers than K562, whereas the bottom 1k peaks have only one SE 
and 35 TE in MCF7 cells whereas K562 cells have 55 SE and 364 TE (Fig 3.38). This 
result show that there are enhancers and super enhancers that can be detected by ATAC 
signals and are specific to each cell type. 
 
 
Figure 3.37.  ATAC-seq signals from unique peaks arise from promoter-distal 
regions. Top 1000 and bottom 1000 ATAC-peaks annotation showing 



























Figure 3.38.  Unique ATAC peaks are enriched in cell-specific enhancers. Bar plot 
showing distribution of typical enhancers and super enhancers among 
the top 1000 peaks and bottom 1000 peaks in each cell type  
 
 From the UCSC browser shot (Fig 3.39; left) of one of the predicted SEs in K562 
cells at the bottom 1k peaks, it is evident that these enhancers show two distinct states in 
two different cells – while this region is open and accessible in K562 cells, they are closed 
in MCF7 cells. Furthermore, these SEs also respond to stimuli differently – with HS the 
openness is not affected much however with As there is a decrease in peak height 
suggesting that these enhancers might become less accessible with heavy-metal stress. 
UCSC browser shot of MCF7 specific SEs further confirms the observation the presence 
of open cell specific enhancers in MCF7, however the same region is closed in K562 (Fig 
3.39; right). 
 We further asked how many of these cell-specific enhancers are common between 
these two cell types and if any correspond to any of the common pool of enhancers that are 
differentially activated in these two cells. We found there are 4000 TEs and 64 SEs that 
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bottom 1k ATAC peaks correspond to these common enhancers we found there are only 
2% TEs and 0.2% SEs in the top and 0.15% TEs and no SEs in bottom 1k peaks (Fig 3.40).  
 
 
Figure 3.39.  UCSC browser shot showing K562 cell-specific super-enhancer (left) 
and MCF7-specific super-enhancer (right) showing chromatin openness 
in only the specific cell-type whereas is a closed chromatin region in 





Figure 3.40.  Super-enhancers are cell-type specific and do not show significant 
overlap between the two cell types. Barplot showing distribution of 


































































Overlap of ATAC peaks with common 
enhancers
Typical enhancers Super enhancers
83 
 UCSC screenshot of a super-enhancer that is present in both MCF7 and K562 show 
that the enhancer is more accessible in MCF7 cells than in K562 indicating again that same 
enhancers can also be present in different states in two different cell types (Fig 3.41). 
 
Figure 3.41.  Predicted super-enhancers exhibit different states of activity in different 
cell types. UCSC browser shot of a super-enhancer that is present in 
both MCF7 and K562 but is only accessible in MCF7 cells. 
 
 Overall this study shows that different cells utilize different HSR programs when 
exposed to the same stress and these differences are more likely to originate from enhancers 
rather than promoters. Further studies are needed to address more in-depth questions about 
the dynamic states of enhancers in these two cell types and to identify the distinction 
between a predicted SE that is not accessible versus an unpredicted SE. Connecting 
enhancer states with histone marks and transcription might answer some of these questions 


























TRANSCRIPTIONAL DYNAMICS OF POL II DURING HEAT SHOCK 
RESPONSE (HSR) REVEAL DISTINCT MECHANISMS OF REGULATION IN 
DIFFERENT CELL TYPES 
4.1  Functional States of Genes during HSR 
 Heat shock response (HSR) is characterized by three classic features – (i) genome-
wide HSF1 binding at multiple loci, (ii) activation of HSR genes that maintain homeostasis 
in cells during stress and, (iii) genome wide transcriptional repression. In 1980, Susan 
Lindquist noted that if Drosophila cells were exposed to a range of high temperatures, 
those cells completely shut down protein synthesis except for a few HS-responsive genes 
such as hsp70, and undergo massive transcriptional repression (Lindquist, 1980) (Fig 4.1) 
 Recently with the advent of new techniques to measure nascent RNA transcription 
such as GRO-seq, NET-seq, and PRO-seq, multiple studies have been performed to 
uncover Pol II dynamics in mammalian cells and its relationship with gene expression. 
Unlike Drosophila, mammalian transcription at elevated temperature continues largely 
unabated across the genome103 (Fig 3.7A). Transcriptional repression of genes in HS, while 
extensive, affects only a proportion of active genes (~ 49% of active genes and ~34% of 
all genes according to Mahat et al., 2017) that is typical of a normal response to stimuli 
such as hormones (50% downregulation of active genes in response to estrogen, Hah et al, 




Figure 4. 1  Massive repression in Drosophila cells on exposure to heat. Gel 
electrophoresis of Schneider 2 cells of Drosophila exposed to different temperatures for 
1h and labeled with [3H]leucine showing massive repression of proteins with increased 
heat except for heat-shock proteins (molecular weight around 80KD). Picture reused from 
Lindquist et al, Developmental Biology, Volume 77, Issue 2, 15 June 1980, Pages 463-
479 with permission.  
 
 The mechanisms of transcriptional repression are still debatable. According to one 
school of thought regulation happens during Pol II recruitment at promoter; during stress, 
recruitment is blocked and hence there is repression. In contrast, another hypothesis 
suggests repression is a result of increased Pol II pausing and decreased release of Pol II 
into gene bodies (Fig 4.2). 
 There are also controversies regarding how Pol II exists in the cell. According to 
Hieda et al, 2005, in Chinese hamster ovary cells, there are three distinct populations of 
Pol II – (i) a hypo-phosphorylated form that is mobile and freely available for recruitment, 
(ii) a hyper-phosphorylated form that is bound to promoter and dissociates on repression 




Figure 4. 2.  Two possible models of gene repression: by blocking Pol II recruitment 
at promoter (left) and by blocking Pol II release onto gene body (right) 
with stress. 
 
elongation phase of transcription is blocked. They show with imaging techniques such as 
FRET that upon heat shock at 42°C, Pol II is dissociated from chromatin and this 
dissociation of Pol II away from promoters leads to repression of transcription. This 
dissociation is transient and steady-state transcription is recovered after incubating the 
heat-shocked cells for 4.5h at physiological temperature112. 
 In this section of my dissertation, I would address the mechanisms of genome-wide 
transcriptional changes in response to HS in MCF7 cells. To understand if same cells use 
different mechanisms of transcriptional response in different stresses inducing HSR 
pathway, I would expose MCF7 cells to Arsenic (As) and measure the effects using PRO-
seq and ChIP-seq against Pol II. To further dissect transcriptional mechanisms, we asked 
if a completely different cell type is exposed to the same stress inducing HSR, will the 
mechanisms of gene activation or repression be the same or change with cell type.  
4.2  MCF7 Cells Do Not Show Evidence of Massive Repression upon HS or As 
 To determine if MCF7 cells exhibit a massive repression such as is observed in 
Drosophila, we performed nascent run-on transcription experiments on MCF7 at different 
time points of HS treatment: 12 min, 30 min, and 60 min to detect global changes in nascent 
Repression blocks recruitment
NHS HS NHS HS
Repression blocks release
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transcription. PRO-seq analyses of MCF7 cells reveal that there is no massive repression 
of genes upon HS treatment, as was previously observed by Mahat et al., 2016 in mouse 
fibroblast cells. Only 27 genes (0.0001%) and 3779 genes (0.16%) were found to be 
repressed at 12 min, and at 30 min, respectively. However, unlike what has been reported 
by Mahat et al., 2016 that increased periods of HS led to increased gene repression, we saw 
with 60 min of HS treatment, the number of repressed genes goes down to 767 from 3779.  
 This result contradicts the massive genome-wide repression of non heat-shock 
genes observed in Drosophila. To determine if this lack of massive repression is a HS-
specific event, we used a HS-independent stimulus and exposed MCF7 cells to 1h of 
500µM As at ambient temperature. Exposure to As led to 5.3 times more repressed genes 
at 60 min than HS in MCF7 cells. However, majority of the genes remain unaffected 
(Fig 4.3). 
 
Figure 4. 3.  MCF7 cells do not undergo massive repression in response to HS or 
As. PRO-seq analysis of gene body counts using DESeq2 pipeline (p < 
0.01) showing number of activated and repressed genes in MCF7 cells 


























4.3  Validation of HS System in Published Mammalian HSR Model: K562 Cells 
 To determine differences in number of repressed genes and the extent of repression 
is not due to experiments having been done in different laboratories and could possibly be 
technical, we used K562 cell line which is a validated model system for HS and exposed 
them to 60 min of HS or 60 min of As. RT- qPCR analysis of HS-target genes in K562 
show upregulation of mRNA with HS or As. Although with As in K562 cells, response is 
less robust (Fig 4.4). 
 
 
Figure 4. 4.  K562 cells respond to HS or As. RT-qPCR results showing K562 cells 
respond to both HS (left) and As (right), similar to MCF7 cells. 
 
 PRO-seq analysis on our K562 cells reveal that these cells undergo greater 
repression of gene expression on exposure to HS or As than those of MCF7 cells. The 
numbers of activated and repressed genes upon HS in K562 cells are comparable with 
previously published data in these cells (Fig 4.5) and validate our observed differences in 
the extent of gene repression between the two different cell lines. 
 This validates the HS treatment performed in our lab and that the lack of repressed 
































































Figure 4. 5.  K562 HS data is comparable to published data confirming validity of 
heat-shock treatment. PRO-seq analysis of gene body counts using 
DESeq2 pipeline (p < 0.01) showing number of activated and repressed 
genes in K562 treated with HS and As in lab (left); (right) published 
K562 PRO-seq data on HS treated cells analyzed using the same 
pipeline as ours showing similar numbers of activated and repressed 
genes. 
 
4.4  Difference in Number of Repressed Genes in K562 Versus MCF7 Cells Is Not 
Due to Difference in the Number of Active Genes at Ground State 
 Since K562 demonstrated 7.3 times more repressed genes than MCF7, we were 
curious if this difference in repression between the two cell types is an effect of different 
number of active genes at ground states of the cells. To test this possibility, we categorized 
genes that had less than 1 read per kb density at gene body regions as inactive genes and 
genes that had more than 1 read per kb density at gene body regions as active genes. As 
expected, we found the number of active genes and inactive genes are very similar in both 












































Figure 4. 6.  Active and inactive genes at ground state between the two cell lines are 
similar in number. Venn diagram showing gene overlap between active 
genes (left) and inactive genes (right) in MCF7 and K562 cells. 
 
4.5  Majority of the Activated and Repressed Genes Overlap between  
the Two Cell Types 
 To investigate if HS or As affect different genes in the two cell types, an overlap 
was done using VennDetail Shiny App (http://hurlab.med.und.edu:3838/VennDetail/). 
54% of genes that are upregulated and 53% of genes that are downregulated in HS in MCF7 
are common to K562. The numbers are similar also in case of As response (Fig 4.7). This 
is consistent with what we observed with respect to HSF1 binding at promoters between 
the two cell types. These results indicate that although the two cells differ in the number of 
genes affected, there is a core group of HS response genes that, irrespective of cell type, 
will respond similarly consistent with their dependence of HSF1 binding. 70% of HS-
overlapped genes and 63% of As-overlapped genes show HSF1 binding upon upregulation 
of gene expression with the treatments. 
Active genes at NHS Silent genes at NHS
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Figure 4. 7.  Both cell types exhibit a common pool of activated and repressed 
genes. Venn diagram showing overlap between different cell types 
MCF7 and K562: HS-upregulated genes (a), HS-downregulated genes 
(b), As-upregulated genes (c), and As-downregulated genes (d). 
 
 Interestingly when we overlap genes that are upregulated or downregulated in HS 
and As, there is an overlap of more than 50% genes in MCF7 cells in both cases. However, 
although the number of downregulated genes common between HS and As in K562 is more 
than 66%, the number of upregulated genes is less than 35% (Fig 4.8). These results 
indicate that the genes that are repressed in HSR are very similar between different stressed 







Figure 4. 8.  K562 shows greater difference in common genes upregulated in HS 
and As than MCF7. Venn diagram showing overlap between different 
treatments HS and As subjected to either MCF7 or K562: MCF7 
upregulated genes (a), MCF7 downregulated genes (b), K562 
upregulated genes (c), and K562 downregulated genes (d) 
 
4.6  Stress Response is Mediated through a Common Cohort of Genes Conserved 
Across Distinct Cell Lines and in Distinct Stresses  
 We next asked which functional pathways do the genes that are common, and 
unique in different cell types and different conditions belong (Fig 4.4 and Fig 4.5). To 
address that, we used Bioconductor packages and Reactome Pathway database, and 
characterized the gene-lists using 3 different GO categories – Cellular Components (CC), 
Biological Functions (BP), Molecular Functions (MF), and KEGG pathway analysis. Only 





 A majority of genes that show upregulation in MCF7 and K562 cell lines with HS 
treatment are the ones involved in temperature and heat sensing, heat acclimation, genes 
involved in protein-folding and genes involved in estrogen signaling pathway (Fig 4.9).  
 Similarly, with As treatment, genes that are involved with heat-shock sensing, 
protein folding, and MAPK pathway are upregulated (Fig 4.10). Rapid upregulation of 
MAPK pathway with acute As stress has also been observed previously in immortalized 
human keratinocyte cells (Cooper et al, 2004).  
 Downregulated genes in both cell types in response to HS include genes that are 
responsible for cell-cycle transitions, DNA replication and chromatin binding indicating 
that under stress these pathways are universally shut down to maintain fidelity of 
replication in cells (Fig 4.11). 
 Downregulated genes in both cell types in response to As include gene that are 
responsible for development and maintenance of cellular systems and downregulation of 
genes involved in p53 pathway. Genes in p53 are known to as tumor-suppressors and 
exposure to As can lead to tumorigenic effects by blocking that pathway (Fig 4.12). As is 
already known to be a potent carcinogen by International Agency of Cancer Research 
(IACR).  
 Uniquely activated genes in MCF7 with HS are involved in blocking activation of 
pathways by negative regulation of phosphorylation and in RNA localization whereas in 




Figure 4. 9.  HS activates a core gene network involving genes responsible for 
sensing temperature, regulating protein misfolding and genes in 
estrogen signaling pathway. Pathway analysis of common HS-
upregulated genes between MCF7 and K562;  
(a) Biological Processes involved  
(b) Molecular Functions involved 








negative regulation of inclusion 
body assembly
regulation of inclusion 
body assembly
protein refolding
response to unfolded protein
regulation of cellular response 
to heat
cellular response to heat
protein folding
response to heat
response to temperature 
stimulus



















protein binding involved in 
protein folding
C3HC4−type RING finger domain 
binding
natural killer cell lectin−like receptor 
binding
unfolded protein binding
heat shock protein binding
ubiquitin protein ligase binding
















Arginine and proline 
metabolism
Longevity regulating 
pathway − multiple species
Legionellosis
Antigen processing and 
presentation
Estrogen signaling pathway
Protein processing in 
endoplasmic reticulum














Figure 4. 10.  As activates heat-shock proteins, stress-sensing pathways and MAPK 
pathway in both cells. Pathway analysis of common As-upregulated 
genes between MCF7 and K562; (left) Molecular Functions involved 
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Figure 4. 11.  Both cells shut down processes that involving DNA replication and 
cell-cycle transition possibly to maintain fidelity in cells. Pathway 
analysis of common HS-downregulated genes between MCF7 and 
K562;  
(a) Biological processes involved  
(b) KEGG pathway. 
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Figure 4. 12.  As exposure leads to downregulation of p53 pathway in both cells, 
hence exerting its carcinogenic activity. Pathway analysis of common 
As-downregulated genes between MCF7 and K562;  
(a) Biological processes involved  
(b) KEGG pathway analysis 
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Figure 4. 13.  Uniquely activated genes in MCF7 (a) and K562 (b) with HS are 
responsible for maintaining RNA fidelity and regulating different 
metabolic processes respectively. Pathway analysis of unique HS-
upregulated genes in MCF7(a) and K562 (b). 
 
 Uniquely activated genes in MCF7 with As are involved cytoskeletal organizations 
and inflammation (Fig 4.14 a) whereas in K562, unique genes are involved in inflammatory 
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Figure 4. 14.  Uniquely activated genes in MCF7 (a) and K562 (b) with As are 
responsible for triggering various inflammatory pathways. Pathway 
analysis of unique As-upregulated genes in MCF7(a) and K562 (b). 
 
 Uniquely repressed genes in MCF7 (Fig 4.15 a) and in K562 (Fig 4.15 b) with HS 
are involved in regulating various metabolic processes and RNA processing. 
 These results show that there is a common cohort of genes that are conserved across 
cell lines and treatments and respond to similar stimuli in the same way to protect cells 
from stress. The genes that vary between cell lines and treatments are the genes primarily 
involved in metabolic processes and cytoskeletal activity, which confirms Susan 
Lindquist’s predictions (1986) where she postulates that the metabolic pathways are what 
determine cell specificity or stimulus specificity whereas the core-response genes remain 
same all across. 
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Figure 4. 15.  Uniquely repressed genes in MCF7 (a) and K562 (b) with HS are 
responsible for cell-specific metabolic processes. Pathway analysis of 
unique HS-downregulated genes in MCF7(a) and K562 (b). 
 
4.7  Mechanisms of Pol II Dynamics in HS or As Activated and  
Repressed Genes in MCF7 and K562 
 Previous results indicate that both cell types activate a group of HS-core response 
genes in stressed conditions and repress metabolic genes specific to cell type. As, which is 
a potent carcinogen, activates tumorigenic pathways and represses anti-tumor pathways. 
However, it is important to address whether these genes were activated or repressed in a 
similar fashion in both cells and in both conditions to understand the dynamics of gene 
regulation by Pol II.
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4.8  Transcriptional Activation Occurs by Release of Pol II into  
Gene Bodies in Both Cell Types and Treatments 
 Most eukaryotic genes have bound Pol II at their promoter region23. These bound 
Pol II remain paused at promoter region and can either continue to make a full transcript 
or can abort transcription, depending on the stimulus. To address whether MCF7 or K562 
cells utilize the same mechanism of activation in response to stress, we took genes that are 
activated either in HS or As in MCF7 and K562 and plotted their average signal at the 
promoter region from PRO-seq data. In both HS-treated MCF7 cells and K562 cells, 
paused Pol II is released from the promoter into the gene body resulting in activation of 
gene transcription (Fig 4.16). This mechanism of Pol II pause release has also been 




Figure 4. 16.  Activation of gene transcription takes place through pause release. 
Profile of all HS-activated genes at NHS and HS condition showing 
release of Pol II in MCF7 (a) and K562 (b). 
 
 In As-treated MCF7 cells (Fig 4.17 a) or in K562 (Fig 4.17 b) cells under both 
stresses, there is an increase in Pol II recruitment at promoter and increased release of Pol 


















Fig # : RT-qPCR data on heat-shock treated K562 cells (n=3, p< 0.05)
Non-parametric unpaired t-test followed by Mann-whitney test.
Fig # : RT-qPCR data on arsenic treated K562 cells (n=3, p< 0.05)



































































































Fig # : RT-qPCR data on heat-shock treated K562 cells (n=3, p< 0.05)
Non-parametric unpaired t-test followed by Mann-whitney test.
Fig # : RT-qPCR data on arsenic treated K562 cells (n=3, p< 0.05)
















































































Figure 4. 17.  Activation of gene transcription takes place through pause release in 
As. Profile of all As-activated genes at NHS and As condition showing 
release of Pol II in MCF7 (c) and K562 (d). 
 
 We visualized PRO-seq data (BigWig files) on UCSC genome browser and 
confirmed that both MCF7 and K562 activated genes show similar mechanisms of 
transcription activation. We looked at several HS-activated genes including DNAJB1 
which has been previously shown113 to be upregulated with HS in K562 cells (Fig 4.18). 
 These results indicate that the mechanisms by which gene activation take place are 
consistent between cell types and across treatments (Fig 4.19). 
4.9  Transcriptional Repression Takes Place through Distinct Mechanisms  
in Different Cell Types  
 We next asked if repression of transcription in response to HS or As follows the 
same mechanisms in different types of cells. We used the same method for plotting average 
PRO-seq signal at promoters of repressed genes as we had used for activated genes. When 
we compared HS-treated MCF7 and K562 cells, we saw differences in Pol II regulation. In 
MCF7 cells, repression occurred by blocking recruitment of Pol II at promoter. In K562, 
recruitment appeared to be largely unaffected in repressed genes; however, there was less 
release of Pol II from promoter to gene bodies leading to accumulation of Pol II at 






























Fig # : RT-qPCR data on heat-shock treated K562 cells (n=3, p< 0.05)
Non-parametric unpaired t-test followed by Mann-whitney test.
Fig # : RT-qPCR data on arsenic treated K562 cells (n=3, p< 0.05)















































































Fig # : RT-qPCR data on heat-shock treated K562 cells (n=3, p< 0.05)
Non-parametric unpaired t-test followed by Mann-whitney test.
Fig # : RT-qPCR data on arsenic treated K562 cells (n=3, p< 0.05)




















































































Figure 4. 18.  Mechanism of activation of gene is conserved in both cell lines and in 
both treatments. UCSC browser shot of a HSR gene DNAJB1 that is 
shown in K562 (top) and MCF7 (bottom) to be activated by Pol II 
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Figure 4. 20.  Repression of gene transcription occur by different mechanisms in 
different cells. Profile of all HS-repressed genes at NHS and HS 
condition showing repression occurs by retention of paused Pol II in 
K562 (a) whereas in MCF7, recruitment of Pol II is decreased (b). 
 
 Similarly, when we compare As – treated MCF7 and K562 cells, we see similar 
differences in mechanisms between the two cells. However, the mechanisms of repression 
remain the same within the same cell type exposed to two different stimuli (Fig 4.21). 
 From these results we conclude that transcriptional activation may occur 
universally by releasing paused Pol II into gene body; however, mechanisms of 
transcriptional repression is distinct to cell type. 

































Figure 4. 21.  Repression of gene transcription occur by different mechanisms in 
different cells with As stress. Profile of all As-repressed genes at NHS 
and As-treated condition showing difference in repression between 
MCF7 (a) and K562 (b). 
 
4.10  HSR Genes Activated Both in MCF7 and K562 Show Variant  
Mechanisms of Transcription Repression  
 To determine if differences in mechanisms are driven by properties of genes or 
environment specific to the cell type, we took genes common to MCF7 and K562 that are 
either upregulated or downregulated for each of the treatments and generated PRO-seq read 
counts at promoter region. We plotted these overlapping differentially regulated genes (all 
DE genes), overlapping up-regulated and down-regulated genes for NHS, HS and As in 
MCF7 and K562 cells (Fig 4.22).  
 Both up-regulated and down-regulated genes have a higher or similar median value 
in HS than in NHS in K562 cells, indicating that there is accumulation of Pol II at 
promoters. Similarly, with As treatment in K562, upregulated genes show increase in Pol 
II level at promoter as expected while downregulated genes barely show any difference 
from their NHS states indicating decrease in release of paused Pol II from promoters 
































Figure 4. 22.  Common downregulated genes between K562 and MCF7 show 
repression by retention of Pol II in K562 cells. Boxplots showing Pol II 
reads at promoter of common DE genes, up genes and down genes at 




Figure 4. 23.  Common downregulated genes between K562 and MCF7 show 
repression by retention of Pol II in K562 As-treated cells. Boxplots 
showing Pol II reads at promoter of common DE genes, up genes and 
down genes at NHS state (left) and with As (right).
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 Contrary to this observation, in MCF7 cells these same genes behave differently. 
With HS, upregulated genes show increase in Pol II while downregulated genes show 
decrease in Pol II at promoter indicating decrease in Pol II recruitment at promoter. With 
As, this mechanism of Pol II retention at downregulated genes is similar to that of MCF7 
cells (Fig 4.24). 
 
 
Figure 4. 24.  Common downregulated genes between K562 and MCF7 show 
repression by decrease in recruitment of Pol II in MCF7 HS-treated 
(top) and As-treated (bottom) cells. Boxplots showing Pol II reads at 
promoter of common DE genes, up genes and down genes at NHS state 
(left) and with HS or As (right).
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 Hence, this result shows that genes are regulated by the properties of the cells rather 
than their own property. Same genes that are downregulated with HS or As in both MCF7 
and K562 show different mechanisms of repression, depending on the cells. 
4.11  MCF7 Cells Switch on Self-Compensatory Mechanism to Maintain 
Transcription on Prolonged Heat Shock 
 Since MCF7 cells showed different mechanisms of transcriptional repression upon 
HS, we were curious if these events are true for other time points too. To address this 
question, we analyzed MCF7 HS at 12min and at 30min and plotted PRO-seq signal for 
the activated and repressed genes. Interestingly, we found at earlier time points MCF7 cells 
exhibit similar mechanism of repression as K562 cells. HS-activated genes in MCF7 at 
earlier time points show increased recruitment of Pol II and increased release to gene body 
and HS-repressed genes show retention of paused Pol II at the promoter. However, with 
increased exposure to HS we see a sharp decrease in paused Pol II population at promoters 
of repressed genes. These results indicate that cells switch their mechanisms of gene 
activation or repression depending on the duration of the stress response and based on the 
availability of factors responsible for transcription (Fig 4.25). 
4.12  A Majority of Pol II Bound Sites are Present at Ground State in MCF7 Cells 
 We next sought to address if Pol II peaks are acquired as a response to HS or if they 
are present in unstressed condition. To address that we did ChIP-seq against Pol II in NHS, 
HS, and As treated MCF7 cells to characterize the status of Pol II in different treatment 
conditions. We did not find major changes in the number of genome-wide Pol II peaks 
called in NHS, HS and As conditions. However, a slight decrease in Pol II peaks was 




Figure 4. 25.  MCF7 switch mechanisms of repression in response to HS in a time-
dependent manner. PRO-seq profiles of repressed genes in  
(A) 12 min of HS,  
(B) 30 min of HS, and  
(C) 60 min of HS showing dynamic changes in Pol II activity within 
the same cell responding to the same stress. 
 
 Moreover, overlapping Pol II peaks called in each condition points out the fact that 
most of the Pol II bound regions were already present at NHS state. 62% of the total number 
of peaks occurring in NHS, HS, and As combined are common among these three 
conditions indicating that genes are already present at a poised state ready for activation at 



























Figure 4. 26.  Genome-wide Pol II peaks remain mostly unchanged with HS or As. 
Barplot representing the number of Pol II peaks called in each 





Figure 4. 27.  Genome-wide Pol II binding sites are established at ground state. Venn 
















4.13  Dynamic Changes in Pol II Peaks at Promoter-distal Regions on Exposure to 
Heat and Arsenic 
 We next addressed where these Pol II peaks are located in the genome. We first 
annotated peaks that are called in each condition namely NHS, HS, and As separately and 
found, as was expected, majority of the peaks in each condition are located at the promoter 
regions (Fig 4.28).  
 
 
Figure 4. 28.  Majority of Pol II peaks are located at promoter regions in all 
conditions. Venn diagram showing location of Pol II peaks in NHS (A), 
HS (B) and As (C) condition. 
 
 We then annotated the peaks that are exclusively present in NHS condition but are 
lost with either of the stresses. Surprisingly we found more than 54% of these peaks belong 
to promoter-distal regions and only ~ 14% of these peaks belong to the promoter (1kb) 
region (Fig 4.29).  
 We then annotated peaks that are present in all three conditions and found that 84% 



































Figure 4. 29.  Changes in global Pol II binding are more pronounced at promoter-
distal regions. Venn diagram of unique Pol II peaks in NHS condition 
showing almost 3 times more enrichment of these peaks at promoter-





Figure 4. 30.  Pol II peaks that are consistently present among all conditions belong to 
promoters. Venn diagram of overlapping Pol II peaks in NHS, HS, and 
















 These results indicate that the distal intergenic regions are more dynamic in 
responding to stresses - ‘potential enhancers’ that do not get activated lose Pol II with stress 
and probably these Pol II get recycled and are recruited at promoters and enhancers of 
genes that are activated with stress.  
4.14  Chromatin Openness and Pol II Occupancy are Correlated and Not Affected 
by Changes in Pol II Binding with Stress 
 We next sought to address if chromatin openness is associated with Pol II 
occupancy, as Pol II binding is known to be not very specific. We plotted Spearman 
correlation between Pol II reads at promoter (+/- 1kb) from ChIP-seq data, and ATAC-seq 
reads at gene promoter (+/- 1kb). Comparison between Pol II reads and ATAC-seq reads 
of all genes in hg19 human genome assembly database showed a high Spearman correlation 
of 0.79 (Fig 4.31 A, top). With HS, this correlation remains almost unchanged with a co-
efficient of 0.72 (Fig 4.31 A, bottom). We next looked at genes that are either upregulated 
(Fig 4.31 B) or downregulated (Fig 4.31 C) with HS. Both categories of genes are well 
correlated in their Pol II occupancy and chromatin openness in NHS (Fig 4.31 top) and 
even in HS (Fig 4.31 bottom) state.  
 Pol II binding and ATAC-seq reads in As- treated MCF7 cells are also highly 
correlated between each other in both untreated (Fig 4.32 top) and As- treated conditions 
(Fig 4.32 bottom). 
 These results indicate that chromatin accessibility may influence Pol II binding, is 
stable and remain mostly unaffected with rapid stress responses. 
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Figure 4. 31.  ATAC-seq and Pol II peaks are highly correlated in NHS and HS 
treated MCF7 cells. Scatter plot distribution expressed in log-scale of 
all genes (A), HS-upregulated gene (B), and HS-downregulated genes 





Figure 4. 32.  ATAC-seq and Pol II peaks are highly correlated in NHS and As 
treated MCF7 cells. Scatter plot distribution expressed in log-scale of 
all genes (A), As-upregulated gene (B), and As-downregulated genes 
(C) in NHS (top panel) and As (bottom panel) conditions. 
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CHAPTER 5 
IL-1b INDUCES GLOBAL TRANSCRIPTOMIC CHANGES IN DISTINCT 
ENHANCERS AND ASSOCIATED GENES IN A TIME-DEPENDENT MANNER 
5.1  Transcription Regulation during Inflammation 
 Promoters and enhancers regulate transcription when cells are exposed to 
intracellular stimuli such as inflammatory molecules. Inflammation is a double-edged 
sword – inflammation needs to be precisely regulated in the cells to avoid continuous 
production of inflammatory molecules in the cells that can lead to various diseases 
including cancer. Hence it is critical to understand regulation of transcription in cells 
exposed to inflammatory molecules.  
 Lam et al., 2013 showed that nuclear receptors Rev-Erb-a and Rev-Erb-b that also 
act as transcriptional repressors can bind to enhancer regions in mouse macrophages and 
regulate eRNA synthesis. They further validated that gain or loss of these transcriptional 
repressors can lead to increased or decreased eRNA synthesis that cause differential 
expression of the target mRNA. However, this changes in binding pattern had no 
significant effect on histone marks further emphasizing the point that histones are stable 
safe keepers of chromatin and majority of them are not altered in rapid response reactions. 
In 2015, Hah et al. studied transcriptional responses in mouse bone marrow cells treated 
with LPS and identified specific super-enhancers that respond to LPS. They showed that 
eRNA transcription is dynamic and transcription is repressed when exposed to LPS for a 
prolonged period of time. 
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 To study how inflammation affects transcription, we exposed human epithelial 
adherent non-small cell lung (NSCLC) adenocarcinoma cells A549 to proinflammatory 
cytokine IL-1b and performed RT-qPCR, Western Blots, RNA-sequencing, and PRO-
sequencing. 
5.2  Physiological Relevance of the Study 
 Inflammation plays a vital role in the development and progression of non-small 
cell lung cancer (NSCLC)114,115,116. It has been shown that infections and inflammation are 
associated with 15-20% of all cancer deaths117,118. A number of different types of immune 
cells such as natural killer cells (NK cells), T-lymphocytes, macrophages, dendritic cells 
(DC), myeloid-derived suppressor cells (MDSCs), and B-cells, infiltrate the tumor and 
along with stromal cells create a lung cancer microenvironment119,120. The chemokines and 
cytokines secreted by these tumor infiltrating cells determine the nature and progression of 
the respective tumors120. Pro-inflammatory cytokines such as IL-1a, IL-1b , IL-6, TNFa, 
TGF-b among multiple others are secreted by these immune cells and also by the tumor 
cells themselves and are released in the microenvironment121. These cytokines play a major 
role in cell proliferation, cell survival and metastasis of tumors115. 
 Inflammation in lungs is not only contained within the organ, but it affects other 
organs as well. Recent studies suggest that lung inflammation has considerable 
contribution to heart diseases122,123,124. For example, chronic lung inflammatory response 
in rabbits directly corresponds to the volume of atherosclerotic plaque deposited on both 
left and right coronary arteries of heart124. Myocardial infarction in humans is nearly 5-fold 
more likely to be triggered by lung inflammation than inflammation in other organs such 
as acute urinary tract infection125,126. Studies show that there is a 30% reduction of 
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hospitalization and death from cardiovascular events in patients that had taken the 
influenza vaccine127,128. There are hypotheses indicating that acute lung inflammation leads 
to systemic inflammation causing release of cytokines such as IL-1b and IL-6 into the 
blood stream122. These pro-inflammatory cytokines cause destabilization of atherosclerotic 
plaques leading to cardiovascular events129. This evidence strongly indicates that cytokines 
released in lung inflammation plays a major role not only in lungs but also in promoting 
cardiovascular diseases. However, the mechanisms by which these cytokines regulate gene 
expression remain largely unknown. 
 It is, therefore, critical to dissect out the basic regulatory mechanisms of how genes 
and gene-regulatory regions respond to inflammatory molecules and bring about changes 
in global transcriptional landscape.  
5.3  A549 Cells Mount up an Inflammatory Response when Challenged  
with IL-1b (Interleukin 1-Beta) 
 To identify which cytokines that are upregulated in lung cancers could mediate a 
robust proinflammatory stimulus in A549 lung epithelial adenocarcinoma cells, we treated 
these cells with various cytokines including IL-1b (Fig 5.1 A), IL-6 (Fig 5.1 B), and TNFa 
(Fig 5.1 C). We also used bacterial Pseudomonas lipopolysaccharide (LPS) (Fig 5.1 D) to 
stimulate pro-inflammatory response in A549 cells and measured mRNA changes using 
pre-reported inflammatory genes that have been shown to respond to these stimuli in other 
cell types.  
 Western Blot was performed on LPS-treated and IL-1b treated A549 cells to 
analyze the effect of these inflammatory molecules at the protein level. The two bands of 
LYN protein correspond to the two isoforms of the protein, 53KD and 56KD, respectively. 
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It is clear that when treated with inflammatory stimuli such as LPS (Fig 5.2 A) or IL-1b 
(Fig 5.2 B), Lyn and NFkB protein levels increase with time from 0 minutes to 5 hours. 
Phosphorylation of LYN is prominent with LPS at 30 min to 5h and with IL-1b at 5h  
(Fig 5.2).  
 
 
Figure 5. 1.  A549 cells treated with a panel of inflammatory cytokines. RT-qPCR 
data showing LYN and RELA mRNA expression in A549 cells 
challenged in IL-1b (10ng/ml) (n=7) (A), IL-6 (10ng/ml) (n=1) 
(10ng/ml) (B), TNFa (10ng/ml)(n=1) (C), and LPS (100ng/ml) (n=2) 
(D). All data are analyzed using parametric paired t-test with a p-value 
cutoff of 0.05. Error bars represent standard deviation. 
 
 Since IL-1b mounts up a robust inflammatory response both at RNA and protein 
level in A549 cells among the cytokines tested, we conducted further experiments using 










































































































































Figure 5. 2.  Inflammatory molecules induce Lyn and NFkB protein levels in A549 
cells. Western Blot in A549 cells induced with LPS (100ng/ml) (A) and 
IL-1ß (10ng/ml) (B) against Lyn, phospho-Lyn, and NFkB showing 
increased levels of these proteins with inflammation. 
 
5.4  Validation of Duration for IL-1b Treatment 
 To address if longer exposure could lead to higher fold of gene activation, A549 
cells were treated with IL-1b for a longer period of time (1-day, 3-day and 5-day). Protein 
and RNA were extracted for analysis (Fig 5.3). 
 
 
Figure 5. 3.  Longer exposure to IL-1ß do not increase inflammatory response of 
A549 cells. Western blot (A) and RT-qPCR (B) on IL-1ß (25ng/ml) 
treated A549 cells (n=1) showing no significant change in Lyn or 


























































 Interestingly, from our western blot results, we observed that the level of 
inflammatory protein expression increases with the number of days the cells were cultured 
in tissue culture dishes even without any IL-1b treatment. Increase in LYN and NFkB 
protein and mRNA expression in 3-day or 5-day treatment was comparable to 1-day 
treatment.  
 Since our goal was to analyze how enhancers control promoter activation in 
response to IL-1b and we observed gene activation with 1-day treatment with no major 
changes in 3-day or 5-day treated cells, we selected the shorter time course. 
5.5  Dose Response Curve of IL-1b Treatment 
 In order to have a concentration of IL-1b that is close to physiological 
concentrations of cytokines, the minimum concentration of IL-1b required by A549 cells 
to trigger inflammation was determined. A549 cells were exposed to 5 different 
concentrations of IL-1b: 0ng/ml (control), 5ng/ml, 10ng/ml, 25ng/ml and 50ng/ml  
(Fig 5.4). Cells were collected 3 days after exposure to IL-1b and mRNA and protein 
concentrations were measured against known target inflammatory genes.  
 
 
Figure 5. 4.  Dose determination of IL-1ß to induce inflammation in A549 cells. RT-
qPCR (A) and Western blot (B) on A549 cells (n=1) treated with a 














































 From RT-qPCR and Western Blot analyses, we chose 10ng/ml as the minimum 
concentration of IL-1b to induce inflammation and have used this concentration for further 
experiments. 
5.6  Role of IL-1b in Lung Inflammation and Cancer 
 The interleukin -1 or IL-1 is a family of multipotent cytokines that plays critical 
roles in physiological and pathological disease states in lungs and other organs of the 
body130. IL-1 family consists of 11 members among which two agonists, IL-1a and IL-1b, 
and an antagonist IL-1 receptor antagonist (IL-1ra), are well studied131. These cytokines 
are recognized by two major receptors, IL-1 receptor Type I (IL-1RI) and IL-1 receptor 
Type II (IL-1RII)130,131,132. IL-1RI is an 80-kD protein found on surface of all IL-1 
responsive cells and is mainly involved in IL-1b signal transduction130. IL-1RII is a 60 kD 
protein bound to the cell membrane and like IL-1R1, shows greater affinity for IL-1 binding 
130,132,133. However, IL-1RII can undergo post-translational cleavage by metalloproteases, 
losing its cytosolic signal-transducing component, thus acting as a soluble form of inhibitor 
protein for IL-1b 130,131,132,133. Therefore, IL-1RII acts as a decoy-receptor for regulating 
IL-1b level in cells and maintaining controlled inflammation. 
 The fine regulation of IL-1b level mediated by IL-1 receptors indicates that IL-1b 
has a major role in regulating inflammation and immune responses. Blockage or excessive 
synthesis of IL-1b has been shown to affect multiple autoimmune diseases such as Type-
II Diabetes mellitus, Sjogren’s Syndrome, Gout and Chondrocalcinosis, pericarditis, 
rheumatoid arthritis, chronic interstitial lung diseases, among many others134. 
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 The role of IL-1b in lungs is complicated. Human lung airway epithelial cells can 
respond to very low levels of IL-1b132. In some studies, bronchial epithelial cells have also 
been shown to produce IL-1b133. (This implies IL-1R I and IL-1RAcP (IL-1R accessory 
protein) act together to amplify the response in lung epithelial cells133. ) Human lung 
epithelial cells can express only IL-1 type I receptors and IL-1R antagonist and not IL-1 
type II receptors. Therefore, the ability of these cells to regulate IL-1b activity is 
compromised and is dependent on inflammatory cells present in the milieu to downregulate 
IL-1b expression through release of IL-1b inhibitors133.  
 These observations indicate that if the inflammatory milieu surrounding the 
bronchial epithelial cells are dysregulated and do not produce IL-1b inhibitors, the 
broncho-epithelial cells themselves will not be able to control IL-1b activity. This makes 
lung epithelial cells an especially interesting model system to study the rapid response to 
IL-1b. It is essential to characterize how this inflammatory cytokine regulates promoter 
activation and gene expression to understand the basic biology of the cytokine and translate 
the mechanisms to disease systems.  
5.7  RNA-Sequencing Reveals Upregulation of Several  
Inflammatory Pathways in IL-1b Treated A549 Cells 
 A549 cells were treated with IL-1b for 0 minutes and 5 hours and RNA were 
sequenced from those cells. The 5-hour time point was selected for RNA-seq using poly-
A selection as it is a measure of polyadenylated (mature) RNAs especially mRNAs that 
take time to accumulate in the cell. Principal component analysis (PCA) and heatmap show 
that treated cells differ from the untreated and also replicates of each condition cluster 




Figure 5. 5.  Validation of replicates and treatments of RNA-seq samples. PCA plot 
(left) and heatmap (right) showing 5-hour IL-1ß (10ng/ml) treated 
A549 cells and the replicates cluster together than untreated A549 cells. 
 
 DESeq2 analysis was performed next on the two replicates to find differentially 
changed genes in response to IL-1b. With a stringent p-value cut-off of 0.01, we found 401 




Figure 5. 6.   DESeq2 analysis of IL-1ß treated A549 cells show robust changes in 
transcriptional landscape. Barplot showing the number of upregulated 
and downregulated genes in response to IL-1ß (p < 0.01). 
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 Some genes with highest fold change for activation include IL-1a, IL-1b, and IL-
6 among other interleukin family of genes. Our RNA-seq results validate the activation of 
signaling molecules involved in IL-1b signaling pathway in A549 cells, that has been 
previously reported in other cell types using various molecular techniques. 
5.8  Signaling Mechanisms 
 IL-1 mediated signaling can occur in a MYD88-dependent canonical pathway131 as 
well as a non-canonical MYD-88 independent pathway. In MYD88 dependent pathway, 
IL-1R1 binds IL-1 molecules and undergoes conformational changes in its extracellular 
domain. This structural change facilitates binding of IL-1RacP forming a trimeric complex 
that rapidly recruits myeloid differentiation primary response 88 (MYD88) and interleukin-
1 receptor-activated protein kinase 4 (IRAK4). These five proteins together form a stable 
signaling complex. IRAK4 undergoes autophosphorylation and dissociates from the 
complex to form IRAK1 and IRAK2. Phosphorylated IRAK1 and IRAK2 recruit tumor-
necrosis factor-associated factor (TRAF) 6 and together phosphorylates and activates 
downstream signaling molecules including TGF-b activated protein kinase 1 (TAK1) and 
MEKK3 signaling complexes. These downstream signaling complexes activate NF-kB, c-
Jun N-terminal kinase (JNK) and p-38 MAPK pathways. In cytoplasm, p38 MAPK 
signaling molecules stabilize IL-1-responsive mRNA containing adenine-uridine-rich 
elements (AREs). This might be the reason we observe IL-1a and IL-1b stable RNA 
transcripts in our 5-hour treated A549 samples.  
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5.9  Pathway Analysis of Upregulated Genes using Reactome Pathway Database 
 KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway analysis of these IL-
1b upregulated genes show most of the upregulated genes fall into cytokine-cytokine 
receptor interaction pathway, TNF-signaling pathway, and NF-kappa B signaling pathway 




Figure 5. 7.  KEGG pathway analysis of IL-1ß upregulated genes showing IL-1ß 
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 Among the upregulated genes, IRAK1 is an essential component of the canonical 
MYD-88 dependent pathway. However, upregulated genes also include several cytokines 
(as is seen in the KEGG analysis) including IL-18R and MAPK that might be involved 
signal transduction via MYD-88 independent pathway in these cells; but this prediction 
needs to be validated by further experiments. Hence, A549 lung cancer cells respond to IL-
1b and activate various cytokine signaling pathways. 
5.10  IL-1b Downregulates cAMP-Signaling Pathway in A549 Cells 
 Unlike in female granulosa-lutein cells of the human ovary where IL-1b 
upregulates the phosphorylation of cAMP-response element binding protein (CREB)132, in 
lung cancer A549 cells IL-1b represses genes in cAMP pathway and Cushing’s syndrome 
(Fig 5.8). This is a novel observation and needs further studies to uncover how cAMP 
signaling pathway is suppressed in A549 cells and what implication it might have in cell 
biology. 
5.11  PRO-Seq Reveals a Disconnect between Promoter-Proximal and  
Gene Body Transcription in Response to IL-1b 
 Since RNA-seq is good only for detecting stable poly-A tailed RNAs, we were 
unable to detect immediate genome-wide transcriptional changes in A549 cells treated with 
IL-1b. In order to identify nascent transcriptomic changes, we performed PRO-seq on 
untreated A549 cells and cells treated with IL-1b for a short time period of 30 min and a 
long time period of 5h. Libraries were first sequenced in MiSeq and then in HiSeq, as is 
mentioned in Methods, and BAM and BIGWIG files were generated using the PRO-seq 
pipeline. BAM files were then processed using published NRSA (Nascent RNA 
Sequencing Analysis) pipeline (Wang et al., 2018) for identification of nascent 
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transcription. Reads were normalized using sequencing depth and a FDR cut off of less 
than 0.05 was set. 
A gene is divided into two parts – promoter-proximal region (pp) which is defined as TSS 
+/- 500bp and gene body (gb) regions which is defined as TSS +1kb to TTS (transcription 




Figure 5. 8.  KEGG pathway analysis of IL-1ß downregulated genes showing IL-1b 
represses genes involved calcium signaling pathway in A549 cells. 
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Figure 5. 9.  Schematic representation of a gene divided into promoter and gene 
body, as has been used for PRO-seq analysis. 
 
 Analysis of reads at promoter-proximal region versus reads at gene-body region 
reveal clear discrepancy between promoter-proximal transcription and gene-body 
transcription in IL-1b treated cells. At 30 min we found changes in 1880 promoter-
proximal regions but only 758 gene body regions as compared to 0 min. Similarly, at 5h 
we found differential expression at 2049 promoter-proximal regions but 763 gene body 
regions (Fig 5.10). 
 
Figure 5. 10.  Evidence of abortive transcription at promoter-proximal regions of 
gene. Barplot showing promoter proximal transcription is higher than 

























 This finding points to the phenomenon of premature termination and abortive 
transcription that has been previously in Drosophila, HIV and other eukaryotic systems. In 
response to IL-1b, transcription initiates at several promoters. However, most of these 
transcriptions are aborted and only genes that are specific to respond to IL-1b ultimately 
undergo full transcription. How this specificity is determined or if these premature 
transcripts have any specific functions are still open questions and would need further 
experiments. 
5.12  Majority of the Genes Body Reads Overlap with the  
Promoter-Proximal Transcripts 
 We next asked how many of these genes that start transcription produce a full-
length transcript. To address that, we overlapped promoter-proximal reads with gene body 
reads and found 52% and 68% of the gene body transcripts at 30 min and 5h respectively 
are extensions of the promoter proximal reads (Fig 5.11).  
 
 
Figure 5. 11.  Majority of IL-1b induced transcripts are overlapping between 
promoter and gene body. Venn diagram showing overlap between 
promoter-proximal transcript and gene body transcript at 30 min (A) 










5.13  Classification of Genes Based on Patterns of Transcription 
 Based on promoter-proximal versus gene body transcription, IL-1b responsive 
genes can be clearly categorized into three distinct categories: 
(a) Genes that show only promoter proximal transcription  
(b) Genes that show only gene body transcription  
(c) Genes that show both promoter proximal and gene body transcription  
Below are UCSC browser tracks of an example gene from each category to highlight the 
differences in transcriptional readouts (Fig 5.12).  
5.14  Gene Body Counts and Promoter-Proximal Counts  
among Different Replicates and Time-Points are Well Correlated 
 To validate that replicates are correlated with each other, we performed Spearman 
correlation test on gene body counts and correlation between replicates is between 80% 
and 90% and correlation between different time points is around or more than 70%  
(Fig 5.13) 
 We ran the same analysis for promoter-proximal reads and found correlation is 





Figure 5. 12.  Three classes of genes categorized based on transcriptional activity. 
UCSC browser shot of gene with only promoter proximal transcription 
(top), only gene-body transcription (middle), and both promoter 



























































Figure 5. 13.  IL-1b induced gene body transcription is well correlation between 
replicates and also among different time points. Heatmap with 
spearman correlation values in small squares between different 




Figure 5. 14.  IL-1b induced promoter proximal transcription is well correlation 
between replicates and also among different time points. Heatmap with 
spearman correlation values in small squares between different 












































30min rep#2 gene body
5h rep#1 gene body
5h rep#2 gene body
0min rep#1 gene body
























































30min rep#1 gene body
30min rep#2 gene body
5h rep#1 gene body
5h rep#2 gene body
0min rep#1 gene body














5.15  Classification of Genes Based on Temporal Response to IL-1ß 
 Depending on the temporal activation or repression of transcription in response to 
IL-1b, genes can be classified as 
a) Early response genes – genes that are differentially regulated at 30 min 
b) Delayed genes – genes that are differentially regulated at 5h 
5.15.1  Immediate Early Genes 
 Genes that have their gene body counts either increased or decreased with a fold-
change cutoff of 1.5 and FDR < 0.05 at 30 min compared to 0 min treated IL-1b are 
characterized as immediate early genes. We find that there are 185 genes that are 




Figure 5. 15.  IL-1b induces rapid changes in transcriptome inducing early genes 
including IEGs. Barplot showing numbers of activated and repressed 
















s Early response genes
138 
 Some of the early activated genes also include ‘immediate early response’ genes or 
IEGs such as JUNB. JUNB is known as a proto-oncogenic transcription factor and 
participates in IL-1b mediated signaling pathways. Hence this shows that IL-1b can trigger 
proto-oncogenic genes in A549 cells including activation of immediate early genes 
involved in IL-1b and NFkB signaling pathways. 
 Pathway analysis of genes that are upregulated at 30 min show increase in 
transcripts of genes involved TNF-a, IL-17, and NFkB signaling pathways. We conclude 
that IL-1b triggers classical inflammatory pathways in A549 cells as early as within 30 min 
of exposure (Fig 5.16).  
5.15.2  Delayed Response Genes 
 PRO-seq analysis of gene body counts of differentially expressed genes at 5h reveal 
that there are 263 genes that are upregulated, and 154 genes are downregulated. (Fig 5.17). 
 Pathway analysis of upregulated genes show that most of the inflammatory genes 
do not show enrichment except TNF. However, delayed response genes such as genes 
involved in metabolic pathways are upregulated at 5h. These genes possibly get activated 
later to maintain homeostasis in stressed cells. 
 We next asked how many of the genes activated at 30 min are still active at 5h. We 
used R intersect function and found 43% of the genes activated at 30 min are still active at 









Figure 5. 17.  PRO-seq reveals nascent changes in transcriptome at 5h of IL-1b 
induction. Barplot showing numbers of activated and repressed genes at 
5h of IL-1b exposure. 
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NF−kappa B signaling pathway
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Figure 5. 19.  Prolonged expression of few early activated genes. Venn diagram 
showing overlap between genes activated at 30 min and at 5h. 
 


























 Although pathway analysis of all genes upregulated at 5h showed only genes 
involved in TNF-a pathway, analysis of only the 81 genes that are common between both 
time points showed consistent activation of the inflammatory pathways that were already 




Figure 5. 20.  Prolonged expressed genes belong to inflammatory pathways. KEGG 
pathway analysis showing active genes common between 30 min and 
5h belong to several inflammatory and infection-related pathways. 
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5.16  Early Genes are Associated with High Enhancer RNA Transcription 
 Immediate early genes that are rapidly upregulated are known to have stronger 
promoters, shorter transcription units and are recently found to be associated with 
enhancers135. We were curious to see if any of these early IL-1ß activated genes by are 
associated with predicted enhancers or not. We chose only those genes that were closest to 
the enhancers (less than 50kb) as the gene-associated with enhancer. Interesting we found 
that 4 out of the 10 enhancers with the highest fold change in eRNA transcription are 




Figure 5. 21.   Early activated gene KLF6 show increased transcription of enhancer 
region. UCSC browser shot of PRO-seq data of KLF6 gene with its 













5.17  IL-1b Caused Rapid Changes in Enhancer RNA Transcription  
 Next, we looked for genome-wide changes in enhancer RNA transcription with IL-
1b and found that 442 predicted enhancers are upregulated and 406 are downregulated with 
a fold-change cutoff of 1.5 within 30 min of IL-1b exposure. With 5h, the number of 
differentially expressed enhancer RNAs do not undergo dramatic increase or decrease 
meaning that enhancers are probably activated quite rapidly in response to stress or 
inflammatory stimuli (Fig 5.22). 
 
 
Figure 5. 22.  IL-1b exposure leads to dynamics changes in eRNA transcription in 
A549 cells. Barplot showing differentially expressed enhancers at 30 
min and 5h. 
 
5.18  KLF6 eRNAs are Activated in Response to Inflammatory Cytokines  
Although the Timing of Activation Varies with Cytokines  
 We next asked whether eRNA transcription is specific only to IL-1b stimulus or is 
it upregulated with other cytokines in IL-1b pathway. We designed qPCR primers targeting 

























Figure 5. 23.  Primer sequences for eRNA detection by qPCR. UCSC genome 
browser showing primers designed against enhancer regions for KLF6 
(top) and ARL8A (bottom) that show upregulated expression with  
IL-1b. 
 
 We performed qPCR (n=1) in A549 treated with IL-1b in short intervals of time: 0 
min, 30 min, 60 min, 120 min, and 5h. We detected upregulation of mRNAs of target 
inflammatory genes such as EGFR and RELA. We also detected upregulation of KLF6, 



























































detected upregulation of KLF6 eRNA at 30 min, but a longer time-course led to decrease 
of KLF6 eRNA (Fig 5.24). Since we were not able to able to detect ARL8A mRNA change 
with qPCR, we focused on dynamics of KLF6 mRNA and eRNA. Furthermore, recently it 
has been confirmed by Syafruddin et al., 2019 using CRISPR deletion that our predicted 
KLF6 enhancer region is actually a super-enhancer that drives KLF6 gene expression in 
renal carcinoma cells136.  
 
 
Figure 5. 24.  KLF6 eRNA level goes down after 60 min. RT-qPCR data against 
several IL-1ß-target mRNAs and eRNAs showing eRNAs are not 
detectable/ goes down after 60min of IL-1ß-treatment in A549 cells. 
 
 We treated A549 cells with other cytokines such as IL-6 (n=1) and TNF-a (n=1) 
that were upregulated in response to IL-1b as detected by PRO-seq and RNA-seq. For both 
IL-6 and TNF-a, we found detectable KLF6 eRNA upregulation, although the timing of 















































Figure 5. 25.  Inflammatory molecules upregulated in IL-1ß pathway is able to induce 
KLF6 eRNA transcription. RT-qPCR results showing IL-6 (10ng/ml) 
(top) and TNF-α (10ng/ml) (bottom) induce KLF6 mRNA and eRNA 
expression in A549 cells.
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5.19  KLF6 eRNA and KLF6 Pre-mRNA are Co-Transcribed  
and are Detected within 15 Minutes of IL-1ß Treatment  
 It is controversial in the field whether eRNA is expressed before mRNA is 
transcribed or simultaneously with mRNA and still can affect mRNA expression. From 
previous results we detected KLF6 eRNA upregulated at 30 min and we saw a burst of 
KLF6 mRNA at 60 min. We were curious if eRNA is actually synthesized prior to mRNA 
in response to IL-1b. To address that, we designed primers against unspliced, pre-mRNA 
state of KLF6 along with processed mRNA transcript. We also designed pre-mRNA 
primers against ACTB, a gene that does not respond to IL-1b as a negative control. Next, 
we treated A549 cells for even shorter time points - 0min, 15 min, 30min, 45 min, and 60 
min and extracted RNA from them. We performed qPCR on these samples, and we 
detected changes in pre-mRNA transcription as early as in 15min, however the major 
detectable changes in pre-mRNA and eRNA was observed at 30 min and mRNA changes 
was pronounced at 45 min. As expected, we did not see any changes in the expression of 
negative control ACTB pre-mRNA (Fig 5.26).  
 Since detection of low abundance transient eRNA transcripts by qPCR is a method 
prone to artefacts unless properly controlled, we ran the qPCR end products with KLF6 
eRNA primers on a 6% polyacrylamide gel with 100bp ladder. We found that the amplified 
products exactly match the length of the region amplified by the target primers indicating 





Figure 5. 26.  KLF6 mRNA and eRNA are activated concomitantly with IL-1b 
induction. RT-qPCR results showing KLF6 pre-mRNA and KLF6 
eRNA expression are both detectable at the same time without any lag 





Figure 5. 27.  KLF6 eRNA amplification is specific and matches expected amplicon 
size. KLF6 eRNA transcripts run on a 6% polyacrylamide gel showing 




























Enh 1: 112bp Enh 2: 103bp 
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5.20  PRO-Sequencing at Shorter Time-Points Confirm Dynamic Changes in KLF6 
eRNA Activation with IL-1b Treatment as Early as 15 Minutes 
 We further performed PRO-sequencing (n =2) of IL-1b treated A549 cell in a 
shorter time course of 0 min, 15 min, 30 min, 45 min, and 60 min (Fig 5.28). As expected, 
we detected a steady increase in nascent transcription of KLF6 eRNA from 15 min to 60 
min of IL-1b treatment, as was previously detected by qPCR (Fig 5.26).  
Hence, we conclude that - 
(i) with IL-1b treatment in A549 changes we could see detectable time-dependent 
upregulation in KLF6 eRNA  
(ii) eRNA and mRNA are co-transcribed and there is no gap in timing of 




Figure 5. 28.  KLF6 eRNA activation can be detected as early as after 15 min of IL-
1b exposure in A549 cells. UCSC genome browser of PRO-seq data 
showing transcriptional changes at KLF6 enhancer region (blue box) 






























 The primary focus of this study is to determine genome-wide changes in the human 
transcriptome during rapid-response to a stimulus. Before the era of next-generation 
sequencing, rapid-response studies were conducted looking at individual genes and their 
changes in expression. Consequently, changes outside the genes were neglected and 
intergenic regions were referred to as “junk DNA”. Genome-wide sequencing studies led 
to a paradigm shift and the field started realizing that these “junk DNA” are, in reality, 
regions that regulate the genes. 
 In the last decade whole-genome mRNA sequencing evolved as the most popular 
method to visualize global changes in transcription in responses to stimuli. However, RNA-
sequencing could not provide accurate measurements of the genome-wide nascent 
transcription that took place during rapid-responses of cells to stimuli, as RNA-seq only 
captured stable, mature RNAs. As a result, we were unable to identify or measure 
transcription of unstable RNAs such as enhancer RNAs (eRNAs). In 2016, Mahat et al. 
published a technique called PRO-seq to identify and quantify nascent RNAs produced 
globally by determining the exact location of Pol II with a single base-pair resolution 
during the response, without using any antibody. This bridged the gap between 
identification of stable RNAs versus unstable RNAs and accounted for the massive changes 
in transcription taking place in intergenic regions. 
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 However, changes in RNA is not the only output of rapid response. To fully 
understand the scope of rapid response to a stimulus, one needs to measure the changes in 
transcription factor binding, changes in various histone marks associated with 
transcription, changes in chromatin openness, and changes in the 3D genome organization 
along with changes in transcription. In our study we followed a combinatorial approach 
and have used PRO-seq, RNA-seq, ChIP-seq, and ATAC-seq to measure rapid changes in 
transcriptome in human cells exposed to various stressors. 
In our study with mammalian breast cancer MCF7 and mammalian leukemic K562 
cells treated with heat-dependent (heat-shock at 43°C) and heat-independent stimuli 
(Arsenic) inducing the same HSR pathway, we show that genome-wide binding of the 
classical heat-shock response transcription factor HSF1 is more sensitive to these stimuli 
than changes in genome-wide transcription. Overall, gene transcription changes by ~ 30% 
whereas number of HSF1 binding sites increases by ~88%. This surprising observation 
indicates that instead of focusing on just transcriptional changes, one should also look at 
transcription factors as a measurable output of cell’s response to a stimulus. Whether this 
increase in HSF1 binding leads to regulation of intergenic transcription or is necessary for 
conformational changes required for transcription are questions that need to be addressed 
in future.  
 The similarity in numbers of HSF1-bound regions versus transcriptional changes 
in both cell types and conditions made us wonder if universal mechanisms are at play that 
do not involve ‘micromanaging’ individual loci and is true for all HSF1-mediated HSR. 
Previous studies by Susan Lindquist and colleagues (Mendillo et al, 2012)137 suggested of 
an HS-independent program that is present in highly malignant cancer cells. Cancer cells 
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with high metastatic potential ectopically activate HSR pathways to activate stress-
responsive genes in the absence of stress as an important adaptation mechanism for 
reprogramming their metabolism. Mendillo et al, proposed of an additional program which 
is stress-dependent and leads to activation of short-term stress response in cells. This and 
other studies revealed an unexpectedly high complexity of HSR program. 
 Addressing the question of whether the response of cells to a stimulus is determined 
conditionally by the stimulus or is rigidly specified by pre-existing interactions at the 
ground state of the cells was critical. Our studies performed on two distinct cell types with 
two distinct HSR-inducing stimuli clearly show that low-grade tumor cells follow the same 
HSR program in heat-dependent and heat-independent stress. HSR mediated by HS or As 
have more than 50% HSF1 binding sites in common and is true for both cell types.  
 Having established that there is one common mechanism that take place within a 
cell irrespective of heat-dependent or heat-independent stimuli, we next asked if the 
mechanism of response is similar between the two types of cells. To our surprise, HSR 
between the two cell types are quite distinct. Although some of the genes activated in the 
two cell types in response to HSR are different, a common core of HS-responsive genes is 
activated irrespective of the stresses or the cell types. However, the major difference lies 
not in the differentially expressed genes but in the regions of HSF1 enrichment. The two 
cells show distinct HSF1 binding patterns to the same stress not at gene promoters, but at 
the distal intergenic regions.  
 We further found HSF1 binding is specific and driven by its motif in both cell-types 
and both treatments. This result shows that HSF1 binding is flexible and its binding sites 
depends on the cell type irrespective of the stimulus. In both cell-types, HSF1 binds only 
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to ~1% of its potential binding sites. This led us to ask the next question of how HSF1 
selects its binding sites. We hypothesized HSF1 binds to specific motifs at open chromatin 
regions, as HSF1 has not been shown to properties of pioneer factors. However, our 
hypothesis was proved false and we found no correlation between HSF1 binding and 
chromatin accessibility. 
 There might be quite a few possibilities of how HSF1 finds its binding site. 
Deriving from our results and existing literature, two of the most probable mechanisms are 
outlined below: 
a) HSF1 might be acting with a co-transcription factor in mammalian cells that is 
located in close proximity to HSF1 binding site and aids HSF1 to select specific 
binding sites either through motif recognition or by loosening of DNA or by both. 
Further experiments need to be conducted to look at stress-responsive trans-
activating domains (TADs) which might serve as potential binding sites for co-
transcription factors and their interaction with HSF1-binding sites during HSR. 
Recently it has been shown that HSR in K562 cells do not lead to TAD re-
arrangements, meaning that these chromatin boundaries might have been already 
established at ground state of cells and do not get rapidly reprogrammed every time 
a stimulus hits a cell (Ray et al., 2019)138. 
b)  Another possibility of how HSF1 selects its binding sites might be similar to what 
has been proposed by Chen et al 139 in the context of transcription factor Sox2. Cells 
might harbor two populations of HSF1 - one that is stably bound to chromatin at 
ground state and the second one is rapidly induced with stress. This second HSF1 
population follows the trail of the already-bound HSF1 at ground state and binds to 
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those specific sites based on cognate-sequence and the hierarchical order set by the 
stably associated HSF1. With the available state-of-the-art techniques such as 
ChIP-seq for determination of genome-wide DNA-binding molecules, it is difficult 
to detect low-intensity chromatin-bound HSF1. However, if we compare HSF1-
bound regions in stressed conditions versus unstressed conditions, we detect most 
(> 80%) of peaks that were present at NHS are still present at HS or As.  
Considering HSF1 binding and genome-wide changes in transcription as two hallmarks 
of HSR, we wondered if mechanisms of Pol II regulation follow a universal pattern or if 
they are condition- or cell-type specific. Pol II ChIP-seq analysis on MCF7 cells in 
unstressed vs stressed conditions reveal that more than 80% of Pol II bound regions at 
ground state remain unchanged with HSR. This is consistent with the concept of 
establishment of transcriptional hubs during lineage determination. Previous studies by 
Mitchell and Fraser, 2007 have found that cells have Pol II factories present at uninduced 
conditions which are ready to respond to any kind of stimuli. Unlike what has been reported 
by Heida et al, 2005 in Chinese hamster ovary cells, we do not observe complete 
dissociation of chromatin-bound Pol II and re-establishment of Pol II factories upon heat-
shock. However, a slight decrease in chromatin-bound Pol II at the intergenic regions with 
HS or As treatment has been noted in MCF7 cells.  
 One of the hallmarks of HSR is massive repression of transcription. Repression 
upon heat shock has been noted in Drosophila 98 and in recent studies of mouse 103and 
human 113. When we considered HSR in MCF7 cells, we observed a similar number of 
genes that are activated with heat shock as is reported. However, we did not observe a 
massive repression and transcription remained unabated in MCF7 cells.  
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 Transcriptional activation of gene expression occurs by increased recruitment and 
release of paused Pol II into gene body. This mechanism of activation is conserved in all 
cell types under all conditions. However, mechanisms of repression appear to be cell-type 
specific. K562 repress gene expression by blocking release of Pol II into gene body without 
any effect on the recruitment of Pol II at promoters. MCF7 cells, on the other hand, repress 
gene transcription by decreased recruitment of Pol II at promoters. Previous studies on 
MCF7 cells induced with b-estrogen (E2) also show repression of genes by blocking Pol II 
initiation. Thus, our study and previous studies on different mammalian cells including 
MCF7 and K562 strongly suggest different cell lines induce transcriptional changes by 
acting on distinct rate-limiting steps – some affecting recruitment versus other affect 
release.  
 The answer to the question why MCF7 cells exhibit decreased Pol II recruitment 
versus K562 has no effect on recruitment but blocks pause release might be in the 
availability of factors that control Pol II recruitment, pause initiation and pause release. 
Studies have shown that lack of active pause release factors such as P-TEFb and Mediator 
complex during HSR can lead to accumulation of paused Pol II at promoters. Another 
important factor of pause-regulation, NELF which initiates pausing have not been much 
looked at in the context of HSR. Our future experiments investigate if one of the pause-
mediating factors such as NELF is knocked down, would that increase repression in MCF7 
cells under heat-shock and provide a justification for the difference in transcriptional 
mechanism in MCF7 cells. 
 When Pol II dynamics was observed at earlier time-points such as 12 min and 30 
min, a similar mechanism of paused Pol II retention was observed, as is seen in K562. At 
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30 min of HS, MCF7 cells show a higher repression of genes as well. These results indicate 
that MCF7 cells might adapt to HSR faster than K562. We propose that initially MCF7 
cells start repressing gene expression by increasing Pol II pausing. Once it reaches a certain 
threshold of accumulated Pol II at promoter or lack of free usable Pol II in the nucleus, 
promoter-bound Pol II is released either into the gene-body or escapes from chromatin into 
the unbound Pol II pool. This Pol II is then used up either by upregulated genes or for genes 
to resume basal level of transcription leading to a decrease in repression. Whether this 
response of MCF7 makes the cells more susceptible to accumulate mutations in proteins 
expressed during stress response is a question that needs to be tested.  
 As mentioned previously, stress responses not only affect transcription regulatory 
proteins and gene expression, but also affects regulatory regions such as enhancers. In a 
different system using inflammatory cytokine IL-1b as a stress inducer in human lung 
cancer cells A549, we measured transcriptional changes in the regulatory regions of DNA.  
 Comparison of promoter-proximal versus gene-body transcription reveal major 
disconnect between transcription initiation and transcription elongation. ~ 72% of genes 
that start transcription in response to IL-1b end up with abortive transcripts and might be 
undergoing premature termination. Such high rate of abortive transcription indicates that 
all genes with transcription initiation machinery probably start rapid transcription with IL-
1β stimulus. Specificity of the response is determined later during pausing whether the 
gene will be activated or remain non-responsive.  
 This observation raises the question how genes (both promoter-proximal and gene-
body) are prioritized for activation or repression. We hypothesized that presence of an 
active enhancer region in close proximity might serve as a template for determining pattern 
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of gene expression. In fact, we found 62% of promoter-proximal regions and 57% of gene-
body regions showed the same pattern of expression as their associated enhancers.  
 This result made us wonder about the timing of transcription and if eRNA is 
transcribed before mRNA setting up the pattern for mRNA expression. However, short-
time course PRO-seq studies and RT qPCR against KLF6 eRNA and mRNA refute the 
idea and reveal that these RNAs are co-transcribed without any delay.  
 In essence, stress response circuits are most likely organized during cell lineage 
determination and stress-response elements belonging to common signaling pathways 
follow similar mechanisms of action. Dynamic changes in cells to stress are most 
pronounced in the intergenic regions or at the potential enhancers that show differential 
eRNA transcription and serve as transcription factor binding sites. Rapid response to stress 
does not lead to major genomic reorganization or changes in histone proteins and remains 
stable during stress response.  
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